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Abstract 
Neurofibromatosis type 1 (NF1) is a genetic condition that is characterized by many 
physical and cognitive signs and symptoms.  Many of the physical manifestations are 
widespread and visible, which may cause an individual to be a target of stigmatization.  
An individual’s perception of this stigmatization could lead to emotional distress and a 
decreased quality of life.  To date, there is no research investigating the underlying 
cognitive factors that drive emotional responses to these negative events in individuals 
with NF1.  More specifically, a literature review reveals no research indicating that 
cognitive distortions or acceptance have ever been studied in this population.  Thus, the 
purpose of this study was to explore the relationship between cognitive distortions, 
perceived stigmatization, and levels of acceptance among adults with NF1 in order to 
inform assessment and treatment of individuals with this disorder.  Adults (n = 48) with 
NF1 volunteered to complete four self-report measures: the Inventory of Cognitive 
Distortions, the Perceived Stigmatization Questionnaire, the Ablon Scale, and the 
Acceptance and Action Questionnaire.  Results indicated that the frequency of cognitive 
distortions was a significant predictor of acceptance.  Furthermore, the frequency of 
cognitive distortions and self-rating of disease visibility predicted level of perceived 
stigmatization.  On the other hand, age at NF1 diagnosis was not a significant predictor of 
level of acceptance.  These results have implications for assessment treatment and 
support the use of cognitive behavioral therapy and acceptance and commitment therapy 
in this population.   
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Chapter 1: Introduction 
Research Questions 
 What is the relationship between cognitive distortions, perceived stigmatization, 
and levels of acceptance in adults diagnosed with neurofibromatosis type 1 (NF1) (World 
Health Organization, 1992; Q85.01)? Specifically, do the frequency of cognitive 
distortions and level of perceived stigmatization among individuals diagnosed with NF1 
predict their level of acceptance? Additionally, does the frequency of cognitive 
distortions and rating of disease visibility among those with NF1 predict their level of 
perceived stigmatization? Lastly, does the age at diagnosis of NF1 predict level of 
acceptance? 
Statement of the Problem 
Neurofibromatosis type 1 (NF1) is a genetic neurocutaneous disorder that affects 
approximately 1 in 3,000 people (Radtke, Sebold, Allison, Haidle, & Schneider, 2007).  It 
is one of the most common genetic syndromes, and its incidence is comparable to that of 
cystic fibrosis (Hart, 2005).  NF1 is a disorder that is characterized by a number of signs 
and symptoms, some of which are highly visible, including multiple brown skin macules 
or darkened spots (café-au-lait spots), skin-folding, freckling, iris Lisch nodules (dome-
shaped elevations projecting from the surface of the iris that are clear to yellow or 
brown), bony dysplasia, neurofibromas, and a predisposition to other benign and 
malignant tumors (Ferner et al., 2007).   
NF1 is transmitted in an autosomal dominant manner, with 50% risk to offspring 
with one affected parent (Wang et al., 2012).  Approximately 50% of cases develop as a 
result of a spontaneous change in one of the NF genes in the egg cell or sperm during 
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conception (Dubov, Toledano-Alhadef, Bokstein, Constantini, & Ben-Shachar, 2016).  
Research shows that individuals with NF1 have an increased risk of experiencing a 
variety of psychosocial issues.  Specifically, NF1 has been linked to depression, anxiety, 
low self-esteem, social withdrawal, behavioral problems, and a lower quality of life 
(QOL) (Granstrom, Mautner, Langenbruch, & Augustin, 2012; Page et al., 2006; 
Wolkenstein, Zeller, Revuz, Ecosse, & Leplege, 2001).  Learning disabilities also affect 
as many as one half of patients with NF1 (Friedman, 2004).   
 NF1 is a variable condition and manifests differently in affected individuals.  
Physical complications, such as café-au-lait spots and cutaneous neurofibromas, occur in 
at least 95% of patients (Tonsgard, 2006).  Lisch nodules, described as reddish brown 
spots in the iris, are present in 90% of adults, and optic gliomas are found in 15% of 
patients (Tonsgard, 2006).  Individuals with NF1 also have abnormalities of growth.  
They tend to have a large head size and short stature (Tonsgard, 2006).   Studies show 
that both the severity and the visibility of NF1 could have negative consequences for 
mental health (Wolkenstein, Zeller, Revuz, Ecosse, & Leplège, 2003), and patients with 
the most visible signs of NF1 report more emotional effects than those with less visible 
signs (Wolkenstein et al., 2001).  NF1 patients appraise their bodies more negatively than 
patients with other disfiguring diseases, and the effect of disease visibility on 
psychological stress is mediated by patient perception (Granstrom et al., 2012).  The 
literature on body image suggests that people with visible disfigurements may experience 
difficulties forming relationships (Thompson & Kent, 2001) and are often a target of 
stigmatizing and dehumanizing behavior (Lawrence, Fauerbach, Heinberg, Doctor, &
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 Thombs, 2006).  Therefore, it is important to consider the underlying cognitive factors 
that contribute to their perception of stigmatization and related distress.   
To date, there is little research exploring the underlying cognitive factors, or 
specific thought patterns, that may influence or directly impact perceptions of the 
condition or level of
acceptance.  Specifically, cognitive distortions and acceptance have never been studied in 
the adult NF1 population.  Because NF1 is highly comorbid with a variety of psychiatric 
and emotional concerns, and cognitive distortions correlate with such mental disorders, 
cognitive distortions are worth exploring among this population (Rosenfield, 2004).   
Cognitive distortions have been studied among a wide range of psychiatric 
disorders.  Individuals who meet criteria for almost any diagnosis on Axis I or Axis II 
report a higher frequency of cognitive distortions than individuals free of psychological 
disorders, and the more severe the disorder(s), the more frequent the reported cognitive 
distortions (Rosenfield, 2004).  Furthermore, individuals meeting criteria for a greater 
number of diagnoses report a higher frequency of cognitive distortions than individuals 
with fewer diagnosable disorders (Rosenfield, 2004).  This indicates that as individuals 
are diagnosed with more disorders, they engage in more cognitive distortions 
(Rosenfield, 2004).  For those with NF1, who have a high comorbidity rate of 
psychological disorders, it is hypothesized that cognitive distortions may play a role in 
the clinical picture.  Specifically, frequency of cognitive distortions may predict a 
patient’s level of perceived stigmatization.  Therefore, cognitive distortions may be an 
underlying factor that drives patient perception of NFI and perceived stigmatization.   
COGNITIVE DISTORTIONS AND NF1   
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It is hypothesized that frequency of cognitive distortions will predict level of 
perceived stigmatization, ultimately impacting an individual’s functioning.  It is 
important to consider how individuals cope with their personal level of functioning and to 
assess their level of acceptance, or psychological flexibility.  Identifying levels of 
acceptance has important implications for assessment and treatment planning among 
those with medical conditions (Dahl, Wilson, & Nilson, 2004).  Treatments based on 
acceptance, such as Acceptance and Commitment Therapy (ACT; Hayes, Strosahl, & 
Wilson, 1999), appear to be effective in improving functional status of
patients with both psychopathology and medical problems (Dahl et al., 2004).  
Acceptance is defined as the willingness to experience events, including those that are 
aversive or unwanted private events, while pursuing one’s values and goals (Hayes et al., 
1999).  There is now accumulating supportive evidence for the effectiveness of ACT 
across a variety of health conditions (Yu & McCracken, 2016).  Within the ACT 
approach, the overarching goal is to increase psychological flexibility, or adaptive 
responding (Beacham, Linfield, Kinman, & Payne-Murphy, 2015, p.  97).  Those with 
higher levels of psychological flexibility can adapt to internal and external cues, allowing 
them to live a life guided by their own values, while reducing the impact of pain, illness, 
loss, and other associated difficulties of an experience (Beacham et al., 2015).  Because 
NF1 tends to be related to physical, cognitive, and emotional distress as well as visible 
disfigurement, the construct of acceptance, or the ability to engage in psychological 
flexibility, may have substantial relevance in the NF1 population.  However, a literature 
review revealed no research exploring cognitive distortions in the NF1 population and 
COGNITIVE DISTORTIONS AND NF1   5 
scant research regarding acceptance and perceived stigmatization in this population.  
Such elucidation could be useful in guiding assessment, treatment, and support.   
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Chapter 2: Literature Review 
Neurofibromatosis Type 1 
As previously stated, Neurofibromatosis type 1 (NF1) is a genetic neurocutaneous 
disorder (Radtke et al., 2007).  Neurocutaneous disorder is a broad term used to describe 
all disorders involving the nervous system and the skin (Barbagallo, Kolodzieh, 
Silverberg, & Weinberg, 2002).  NF1 is believed to date back to 1,000 AD.  The oldest 
cases of the disorder appear in the literature, described by Madigan, Schaw, and Masello 
in Neurofibromatosis in the 13th Century and Report of NF-Like Case - Monstrorum 
History (Antonio, Goloni-Bertollo, & Tridico, 2013).  In 1881, von Recklinghausen 
coined the term neurofibroma (Zanca, 1980, p.  56).  He observed a benign tumor that 
arose from the peripheral nerve sheath, and medical colleagues, in honor of his discovery, 
named the condition von Recklinghausen’s disease (Ferner et al., 2007).  At one time, 
neurofibromatosis 1 and 2 were both known as von Recklinghausen’s disease; however, 
in the latter part of the 20th century, different forms of neurofibromatosis were delineated 
(Ferner et al., 2007). 
The diagnostic criteria for neurofibromatosis type 1 are two or more of the 
following, all of which will be further explained below: (a) six or more café-au-lait spots, 
(b) two or more neurofibromas of any type or one plexiform neurofibroma, (c) bone 
abnormalities, including sphenoid dysplasia (absence of bone surrounding the eye), (d) 
family history of NF1, (e) two or more Lisch nodules, (f) freckles in the axillary (armpit) 
or inguinal (groin) region, and (g) optic pathway glioma (National Institutes of Health 
[NIH], 2017).   
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People with NF1 are usually born with one mutated copy of the NF1 gene in each 
cell (NIH, 2017).  For a tumor to form, two copies of the NF1 gene must be mutated; the 
mutation of the second occurs during a person’s lifetime and is not inherited (NIH, 2017).  
The clinical manifestations of NF1 are widespread and affect many different areas of 
functioning. 
Neurofibromatosis type 2 is less common than NF1, affecting about 1 in every 
25,000 people (Johns Hopkins Medical Center).  The diagnostic criteria for NF2 includes 
bilateral vestibular schwannomas, which are benign tumors grown from an 
overproduction of Schwann cells in both ears (NIH, 2017).  It is now understood that 
these are two distinct genetic disorders affecting two separate chromosomes (Huson, 
1999).   
NF1 is typically diagnosed during childhood, whereas NF2 is more commonly 
diagnosed in late adolescence (Smith et al., 2013).  The long arm of chromosome 17 is 
thought to be the site of the gene defect for NF1 (Legius, Descheemaeker, Spaepen, 
Casaer, & Fryns, 1994).  Chromosomes 2, 14, and 22 have also been implicated in the 
disorder (Hulsebos, Bijleveld, Riegman, Smink, & Dunham, 1996).  The affected gene is 
a tumor suppressor gene that produces a protein called neurofibromin (Hart, 2005).  
Neurofibromin is similar to the protein guanosine triphosphatase-activating protein 
(GAP), which serves as a regulator of signals for cell proliferation and differentiation, 
that may be a factor in some types of cancers and a regulator of chemical interactions and 
cell growth (Rubenstein, 2005; Hart, 2005).  The similarities between these two proteins 
indicate that neurofibromin may play a similar role in cell growth regulation, and a lack 
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of this protein may be responsible for the abnormal cell growth and tumor development 
that occurs in NF1 (Hart, 2005).   
Neurofibromatosis type 3, also known as schwannomatosis (SWN) is a recently 
recognized form of NF.  This disorder affects approximately 1 in 40,000 individuals 
(Evans et al., 2010).  Whereas NF1 is characterized by neurofibromas, SWN is 
characterized by schwannomas.  Neurofibromas and schwannomas are both benign nerve 
sheath tumors, but have different effects on the nerve root in which the tumor is located.  
Diagnostic criteria outlined by the National Institutes of Health for SWN include: (a) two 
or more non intradermal schwannomas (b) no evidence of a vestibular tumor on magnetic 
resonance imaging (MRI) scan (c) no known constitutional NF2 mutation and (d) one 
pathologically confirmed nonvestibular schwannoma and (e) a first-degree relative who 
meets the above criteria.  Although SWN involves symptoms that are similar to NF1, for 
the purpose of this study, only NF1 will be considered.   
Clinical Manifestations and Medical Concerns of NF1 
In order to understand the physical manifestations of NF1, it is important to 
review the basic anatomy of the human nervous system.  The nervous system consists of 
two parts: the central nervous system (CNS), which includes the brain and spinal cord, 
and the peripheral nervous system, which contains nerves all over the body that send 
signals to the CNS.  These signals are sent with the help of nerve fibers that are covered 
in myelin.  Myelin is a substance also known as nerve sheath and protects the nerve fibers 
and helps them send fast signals (Kaiser, 2017).  At times, the cells that create the myelin, 
Schwann cells, can grow uncontrollably, forming a nerve sheath tumor (Kaiser, 2017). 
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One of the most common symptoms of NF1 is neurofibromas, which occur in 
more than 99% of the NF1 population (Ferner, 2007).  Neurofibromas are benign 
peripheral nerve sheath tumors that can be focal cutaneous (in or just under the skin) or 
subcutaneous.  They can appear as purplish depressions in the skin or pedunculated 
lesions that stick out from the skin (Tonsgard, 2006).  Neurofibromas will typically 
develop in the patient’s late teens or early twenties (Ferner, 2007).  Neurofibromas may 
be tender to the touch and cause tingling in the distribution of the affected nerve (Ferner, 
2007).  Plexiform neurofibromas, seen in at least 50% of patients, are similar to 
cutaneous neurofibromas, but have more extracellular matrix (Tonsgard, 2006).  They 
cause significant morbidity because they are diffuse, grow along the length of the nerve, 
and may involve multiple nerve branches (Ferner, 2007).  Plexiform neurofibromas often 
arise from the dorsal spinal roots (roots emerging from spinal cord), nerve plexi 
(networks of intersecting nerves), large nerve trunks, or sympathetic chains (paired 
bundle of nerve fibers) and infiltrate surrounding soft tissue (Ferner, 2007; Tonsgard, 
2006).  Although neurofibromas are benign, there is also the possibility for individuals to 
develop malignant peripheral nerve sheath tumors (MPNST); however, there is only an 
8% to 13% lifetime risk (Ferner, 2007).  MPNSTs usually arise from preexisting 
plexiform neurofibromas, are hard to detect, metastasize widely, and signify a poor 
prognosis (Ferner, 2007).   
One of the hallmark manifestations of NF1 is known as café-au-lait spots.  More 
than 99% of individuals with NF1 will have café au lait spots on their skin, and some 
patients are distressed by their appearance (Ferner, 2007).  These are hyperpigmented flat 
spots, or macules, that are generally round or oval (Tonsgard, 2006).  They are present at 
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the time of birth and will increase in size and number throughout the first 5 to 7 years of 
life (Tonsgard, 2006).  NF1 patients will develop more than five spots within the first 
year of life and spots may continue to develop until age 4 (Debella & Friedman, 2000).  
These macules do not correlate with the number of NF1 tumors; they are benign and do 
not cause any functional disability in the patient (Hart, 2005).  Similarly, skin-fold 
freckling is another type of hyperpigmentation sign of NF1.  This characteristic will 
appear by age 7 and will occur in 90% of individuals (Feldman, Jordan, & Fonseca, 
2010).   
NF1 may also have ocular manifestations, affecting the iris, retina, and optic 
nerve (Tonsgard, 2006).  Patients may have Lisch nodules, which are proliferations of 
melanocytes (melanin producing cells) and fibroblasts (cells that produce collagen) that 
appear as reddish brown spots in the iris (Tonsgard, 2006).  These typically have no 
effect on vision and will appear in the teenage years (Tonsgard, 2006).  Optic pathway 
gliomas (OPG) are seen in about 15% of NF1 individuals and children under the age of 7 
are at greatest risk (Ferner, 2007).  OPGs are the primary central nervous system tumors 
(visual pathway tumors) associated with NF1 and produce thickening of the optic nerve 
(Hart, 2005).  They are frequently bilateral, involve the chiasm, and may extend to the 
optic tracts or the hypothalamus (Tonsgard, 2006).  Some gliomas produce impaired 
visual acuity, abnormal color vision, visual field loss, squint, and hypothalamic 
dysfunction (Ferner, 2007).   
Orthopedic symptoms may be a concern in NF1.  In addition to sphenoid 
dysplasia (NIH, 2017), other common problems are hypotonia (low muscle tone) and 
poor coordination (Tonsgard, 2006).  Bony dysplasia (abnormal bone development), 
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bony erosion, demineralization, nonossifying fibromas (benign bone tumors) and 
scoliosis are all potential features of NF1 (Tonsgard, 2006).  Erosion or demineralization 
is often caused by pressure from adjacent plexiform neurofibromas (Tonsgard, 2006).  
Approximately 5% of individuals with NF1 develop bowing of leg bones below the knee 
(Children’s Tumor Foundation).  This is caused by an intrinsic bone defect occurring 
during early bone development, with bowing often visible in the first few months of life 
(Ferner, 2007).  Because of this concern, children with NF1 need a yearly spinal 
assessment.  NF1 may cause disruption in bone maintenance and reduced bone mineral 
density (Lammert et al., 2005).  Abnormalities of growth are also a common feature of 
NF1.  There is evidence of large head size and short stature (Hart, 2005; Tonsgard, 2006).  
Failure to gain weight occurs in less than 1% of patients in the first 2 to 3 years of life 
(Tonsgard, 2006).   
There is also evidence of neurologic impacts of NF1.  Headaches, seizures, and 
brain tumors are common.  Headaches will occur in 20% of NF1 patients, and most are 
consistent with migraines (Hart, 2005; Tonsgard, 2006).  In addition to the 15% of 
patients that report visual pathway tumors (optic gliomas), another 3% to 5% of patients 
have other types of brain tumors, often on the brainstem or cerebellum (Tonsgard, 2006).  
The reduced neurofibromin in the body provides a growth advantage for astrocytes in the 
brain.  Therefore, these tumors are astrocytic, meaning they originate from astrocytes in 
the cerebellum (Tonsgard, 2006).  Tumors are often identified on MRI.  Seizures, 
although not a common characteristic, occur in up to 10% of patients (Tonsgard, 2006).  
In a study of 536 individuals with NF1, researchers found that 9.5% had a history of at 
least one unprovoked seizure, and 6.5% had documented epilepsy (Ostendorf, Gutmann, 
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& Weisenberg, 2013).  Those with seizures were more likely to have inherited NF1 from 
their mother (Ostendorf et al., 2013).  Focal (partial) seizures were the most common 
type, occurring in 57% of individuals with seizures (Ostendorf et al., 2013).  Not only 
does NF1 have a substantial impact on the physical body, but the disorder also impacts 
neurocognitive functioning. 
Neurocognitive Impact of NF1 
Neurocognitive studies of NF1 patients have focused mainly on children, and data 
in adults are reported less frequently (Descheemaeker, Plasschaert, Frijns, & Legius, 
2013).  However, a handful of studies have examined the impact of NF1 on adult 
cognitive functioning, and deficits have been noted (Pavol et al., 2006).  For example, in 
a study involving 103 patients with NF1, researchers found a significant difference 
between NF1 patients and controls in full scale, verbal, and performance IQ (Ferner et al., 
2006).  However, it is important to note that the intellectual impairment was mild and the 
majority of NF1 patients had IQs in the low-average range (Ferner, Hughes, & Weinman, 
1996).  Results from a study of 20 NF1 adults confirmed this finding and found a mean 
estimated IQ score of 89.96 (Descheemaeker et al., 2013).  Ferner et al.  (1996) also 
found that NF1 patients had higher error rates and slower reaction times on automated 
performance tests, and they were slow to formulate and adapt strategies to cope with 
complex and unfamiliar tasks (Ferner et al., 1996).  NF1 participants were also found to 
have poorer reading, short term memory, and attention skills (Ferner et al., 1996).  
Moreover, NF1 patients had deficits in executive function, visual-spatial abilities, and 
attention (Acosta et al., 2006; Descheemaeker et al., 2013).   
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Adults with NF1 performed significantly lower on tests of visual constructive 
skills in comparison to control groups (Descheemaeker et al., 2013).  In a study 
conducted by Pavol et al.  (2006) involving 20 NF1 patients, results indicated that 
measures of visual and attention-executive function skills discriminated between NF1 
patients and controls.  They also found that receptive vocabulary was a significant 
predictor in discriminating NF1 patients and controls (Pavol et al., 2006).  Learning 
disabilities are common, affect as many as one half of patients with NF1, and can range 
from attention deficit hyperactivity disorder (ADHD) to intellectual impairment (Korf, 
1992).  Learning disabilities and ADHD occur in as many as 60% of patients (Tonsgard, 
2006), and ADHD is thought to contribute to the learning disabilities and poor social 
skills in NF1 (Barton & North, 2004).  Recently, there have been advances in the 
understanding of the molecular, cellular, and neural system underpinnings of NF1-
associated learning deficits in animal models; however, much remains to be learned about 
the spectrum of cognitive, neurological, and psychiatric phenotypes associated with NF1 
(Acosta et al., 2012).  These findings indicate that screening for learning disabilities in 
the early school years is beneficial for early intervention.   
Psychological Impact of NF1 
 Due to the nature of NF1 and its variable physical and cognitive impacts, it is 
important to consider the psychological burden of living with the disorder.  Empirical 
evidence indicates a wide range of psychosocial issues that are common with NFI.  There 
is a consistent pattern of reduced emotional well-being in NF1 patients compared to the 
general population (Wang et al., 2012).  For instance, those with NF1 are at increased 
risk for experiencing social and emotional difficulties, including depression, anxiety, low 
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self-esteem, social withdrawal, behavioral problems, and difficulty forming interpersonal 
relationships (Granstrom et al., 2012; Page et al., 20016; Wolkenstein et al., 2001).  
Levels of anxiety and depressive symptoms in an NF sample of 248 patients were found 
to be higher than those reported by patients with other chronic diseases, including 
coronary artery disease and cancer (Wang et al., 2012).  The same study found that, in 
adults with NF1 and NF2, 37% of males and 46% of females scored at or above the cut-
off of 16 on the Center for Epidemiologic Studies Depression (CESD) scale, indicating a 
high likelihood of clinical depression (Wang et al., 2012).  In a more recent study of 498 
adults with NFI examining depression and quality of life, researchers found that 55% of 
participants scored above a 16 on the CESD, supporting previous findings of increased 
risk for clinical depression (Cohen, Levy, Sloan, Dariotis, & Biesecker, 2015).  
Furthermore, they found that the degree of depressive symptoms was highly correlated 
with quality of life; approximately one third of the variation in QOL was explained by the 
level of depression (Cohen et al., 2015).  Results of a 12 year follow-up study examining 
48 adults with NFI indicated increased frequency of psychiatric symptoms and mental 
disorders (Zöller & Rembeck, 1999).  Of these disorders, dysthymia was the most 
common diagnosis, found in 21% of the NF1 cases (Zöller & Rembeck, 1999).  
Depression, in particular, appears to be quite common among those with NF1 (Cohen et 
al., 2015).   
Adults with NF1 also tend to have significantly less prosocial behavior (Pride, 
Crawford, Payne, & North, 2013).  Interestingly, the higher rate of impairment in this 
area is reported by family members and friends of those with NF1, rather than self-
reports.  This indicates that NF1 patients have reduced awareness of deficits in social 
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skills, which should be considered when selecting strategies and interventions for future 
clinical trials aimed at improving social skills (Pride et al., 2013).   In a study of 62 adults 
with NF1, social deficits were found to have a significant association with executive 
functions and social skills, and adults with more severe deficits in behavioral regulation 
exhibited more frequent antisocial behavior (Pride et al., 2013).  The presence of ADHD 
has also been found to be an important risk factor for poor social skills (Barton & North, 
2004).  Approximately 30% to 50% of these individuals meet the diagnostic criteria for 
ADHD (Hyman et al., 2005).  Studies show that impairments in attention and executive 
functions explain a significant proportion of variance in social skills in disorders 
characterized by social dysfunction (Addington & Addington, 1999).   
In summary, it is clear that NF1 can have varying physical, neurocognitive, and 
psychological impacts.  Because the hallmarks of NF1 are often visible, such as café au 
lait spots, neurofibromas, and skin pigmentation abnormalities, it is important to consider 
how visibility of the condition impacts each individual patient and his or her quality of 
life.    
Visibility, Perceived Visibility, and Stigmatization of NF1 
NF1 symptoms are typically more noticeable than those of NF2, yet both can be 
difficult to conceal (Smith et al., 2013).  Visible plexiform neurofibromas are present in 
30% of patients, and 20% have internal plexiform neurofibromas that are visible through 
imaging (Granstörm et al., 2012).  Visibility of NF1 symptoms may cause significant 
psychological distress and social burden.  Appearance concerns are common among the 
general population: 35% of men and 61% of women (Harris & Carr, 2001).  In 
considering NF1, which manifests in visible symptoms, these concerns may be 
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exacerbated.  In a study of 127 women with NF, researchers found that 85% were 
concerned with their appearance.  Kodra et al.  (2009) found that 40% of patients with 
NF1 reported feeling embarrassed about their skin condition, and more than 20% worried 
about having scars.  In a 2012 study, women with NF1 felt less attractive and self-
confident and more insecure sbout their bodies compared to normative controls 
(Granstörm et al., 2012).  Women with NF1 and NF2 experience a high level of social 
self-consciousness related to their appearance (Smith et al., 2013).  Similarly, patients 
with NF1 who have more visible symptoms report that their skin condition has a greater 
impact on their emotions, mental health, and social functioning (Page et al., 2006).  In a 
study of 60 Australian adults with NF1, researchers found that many of the participants 
reported the visible appearance as the worst aspect of the condition (Crawford et al., 
2015).   
In NF1 patients, disease visibility is associated with psychiatric morbidity that is 
linked to cosmetic impact, and reduces the quality of life (Wolkenstein et al., 2001, 
2003).  Psychiatric problems may arise as a reaction to disfigurement or perceived social 
stigma (Wolkenstein et al., 2003).  Research shows that patients with a higher concern 
about the visibility of their disease are at higher risk of developing low self-esteem, self-
rejecting cognitions, problems in interpersonal relationships, and negative body image 
(Rumsey & Harcourt, 2004).  In a study of 129 Italian adults with NF1, researchers found 
that cosmetic features have a greater impact on all aspects of skin-disease-specific quality 
of life, especially with regard to limitations because of emotional problems, or the 
emotional aspect (Kodra et al., 2009).  In this study, the most frequent items endorsed in 
emotional aspect were being worried that the disease would become worse and would 
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result in a more complex course of the disorder (Kodra et al., 20009).  Similar findings 
were found by Wolkenstein et al.  (2001) in a study of 128 adults with NF1, in which 
patients with the most visible symptoms reported emotional effects of their skin condition 
on their quality of life.  They also reported significantly greater overall effects on their 
skin disease quality of life, which included emotions, physical symptoms, and 
functioning (Wolkenstein et al., 2001).  These findings are further supported by Page et 
al.  (2006), whose study of 169 adults with NF1 yielded the same results.  Appearance 
seems to play an important part in the perception of severity and has a direct impact on 
quality of life and personal body image (Wolkenstein et al., 2003).   
Schilder (1950) first proposed a psychological approach to body image, consisting 
of how a person perceives his or her own body and related attitudes and feelings.  
According to Cash (2011), the cognitive-behavioral model of body image identifies three 
coping strategies in which individuals who experience distressing body-related cognitions 
and emotions commonly engage.  These are: (a) experiential avoidance, or attempts to 
avoid distressing body image cognitions, emotions, and situations; (b) appearance fixing, 
or efforts aimed at correcting or concealing ones’ perceived physical flaws; and (c) 
positive rational acceptance, or behaviors such as self-care and positive self-talk that 
focus on the acceptance of ones’ experiences.  Data from Cash, Santos, and Williams 
(2005) revealed that those who engaged in more body image experiential avoidance also 
experienced greater body image dissatisfaction and dysphoria and lower body image 
quality of life. 
 Literature on body image suggests that people with visible disfigurements may 
experience difficulties forming relationships, particularly with sexual partners 
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(Thompson & Kent, 2001).  Negative body image and perception also have an impact on 
depressive states and distress (Granstörm et al., 2012).  Those with visible disfigurements 
or distinctions are often a target of stigmatizing and dehumanizing behavior (Lawrence et 
al., 2006).  These behaviors can be overt, such as staring, double takes, whispering, and 
teasing, or subtler, such as avoiding eye contact, ignoring, pity, etc.  (Beuf, 1990).  In the 
aforementioned study of 60 Australian adults with NF1, certain participants experienced 
situations in which strangers approached them, made comments, or taunted them about 
their physical condition, which they reported as a distressing, humiliating experience 
(Crawford et al., 2015).  According to Bull and Rumsey (1988), there are three specific 
effects of being a target of these behaviors: poor body esteem, a sense of social isolation, 
and a violation of privacy effect, which refers to a person’s right to remain anonymous in 
crowds.   
Most of the theory and research on the concept of stigmatization can be traced 
back to Goffman (1963).   There have been a number of relevant theories about stigma.  
For instance, Goffman defined stigma as “an attribute that is deeply discrediting” (p.  6).  
More specifically, stigma is a worldwide devaluation of an individual who has an 
attribute or characteristic that is different from most (Goffman, 1963).   Stigma then 
arises during a social interaction when actual social identity does not meet society’s 
expectations or standards (Kurzban & Leary, 2001).  Following Goffman’s work, other 
perspectives of stigma have been noted in the literature.  Jones et al.  (1984) stated that a 
person is stigmatized when a deviation initiates an attributional process through which 
people interpret other aspects of the individual in terms of the deviation.   Another 
perspective proposes that stigma is a form of deviance that leads others to judge 
COGNITIVE DISTORTIONS AND NF1   19 
individuals as illegitimate for participation in interaction (Elliott, Ziegler, Altman, & 
Scott, 1982).  Once the individual is deemed illegitimate for participation, he or she is 
beyond the protection of social norms and may be excluded or ignored (Elliott et al., 
1982).   Lastly, Crocker, Major, and Steele (1998) believe stigma arises from 
membership in a group that is negatively valued in a specific situation.  All of the 
aforementioned theories involve an aspect of negative evaluation and attributions.  
Through the process of stigmatization, certain individuals are excluded from particular 
sorts of social interactions because they possess a particular characteristic or are a 
member of a particular group (Kurzban & Leary, 2001).   
Positive social interaction is a crucial component for psychological and physical 
health.  Those who experience stigmatization are susceptible to a variety of behavioral, 
emotional, and physical problems, suggesting that humans may have an innate need to 
belong (Baumeister & Leary, 1995).  NF1 is not the only disorder that may result in 
negative psychological impacts and stigmatization.  There are a variety of other 
conditions with visible symptoms that could result in similar experiences.   
Psychological Effects of Other Visible/Disfiguring Conditions 
 NF1 is just one of various disorders and skin conditions that present with physical 
symptoms.   Often, these visible differences lead to stigmatization by others that result in 
negative psychological impact.  To provide context, a few of other of these conditions 
will be discussed, such as psoriasis, congenital and acquired facial differences, acne 
vulgaris, genetic skeletal dysplasias, and HIV/AIDS.   
Psoriasis is a chronic skin condition characterized by red lesions on the skin 
(Schon & Boehncke, 2005).  Systematic reviews examining the psychosocial impact of 
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psoriasis demonstrated social stigmatization, high stress levels, physical limitations, 
depression, and employment problems.  They also found high rates of poor self-esteem, 
anxiety, depression, sexual dysfunction and suicidal ideation (Kimball et al., 2005; 
Russo, Ilchef, & Cooper, 2004).  As with NF, patients with psoriasis commonly 
experience stigmatization, which they consider one of the more distressing characteristics 
of the condition (Schmid-Ott et al., 2005).  This experience of stigmatization contributes 
to additional stressors, such as disability, depression, and reduced quality of life, in these 
patients (Richards et al., 2001).  In a recent study examining the predictors of perceived 
stigmatization, researchers found that higher levels of perceived stigmatization were 
correlated with sociodemographic and disease-related variables, personality, illness 
cognitions such as helplessness, and social support (van Beugen et al., 2017).  This study 
stressed the importance of finding interventions to address stigmatization in treatment.   
 Studies have also examined the individuals with congenital abnormalities and 
other facial differences and how these differences impact their perceived stigmatization 
and psychological well-being, specifically pediatric patients with a cleft-lip/palate or 
other craniofacial deformities that compromise speech functions (Carroll & Shute, 2005).  
In a study conducted by Masnari et al.  (2012), of self- and parents perceived 
stigmatization in children and adolescents with congenital or acquired facial differences, 
these children are at high risk for experiencing stigmatizing behaviors.  More specifically, 
they are at risk of behaviors such as staring, startled reactions, teasing, and expressions of 
pity (Masnari et al., 2012).  In regards to psychological and behavioral adjustment, 
adolescents with acquired facial differences have been found to report poorer self-image 
than adolescents with congenital conditions (Patrick et al., 2007); however, this finding is 
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not consistent among adults (Versnel, Plomp, Passchier, Duivenvoorden, & Mathijssen, 
2012).   
Acne vulgaris (AV) is a genetic-hormonal illness effecting the skin that results in 
lesions in exposed areas such as the face and thorax (Vilar, Santos, & Sobral Filho, 
2015).  This common inflammatory condition affects both adolescents and adults 
(Joseph, 2010).  The effect of acne on psychological well-being is significant because it is 
most prevalent during adolescence, which is a time of social, emotional and physical 
development (Joseph, 2010).  Because acne affects the face and thorax, it is highly 
visible, which adds to the psychological burden of the disease; there is evidence in some 
patients of severe psychological impact, leading to clinical depression, anxiety, suicidal 
thoughts, and even suicide (Joseph, 2010).  Studies of quality of life among adolescents 
with acne indicate that there is a correlation between the severity of acne vulgaris and 
lower quality of life; however, self-esteem was not significantly associated with the 
occurrence or severity of acne vulgaris (Vilar et al., 2015).   
Genetic skeletal dysplasias result in similar experiences due to their physical 
burden and impact.  Skeletal dysplasia is an umbrella term that includes a variety of 
disorders that impact bone and cartilage growth.  In a study conducted by Apajasalo, 
Sintonen, Rautonen, and Kaitila (1998), the researchers focused on three specific genetic 
dysplasias: achondroplasia, cartilage-hair hypoplasia, and diastrophic dysplasia.  All of 
these subtypes result in congenital severe short stature (Apajasalo et al., 1998).  Other 
symptoms of these dysplasias include disproportionate short-limbed stature, characteristic 
facial features, sparse hair, and limitation of joint movements (Gorlin, Cohen, & Levin, 
1990; Makitie & Kaitila, 1993).  Findings from the aforementioned study indicate that the 
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perceived health-related quality of life of adult patients with skeletal dysplasias is 
significantly lower than that of health controls (Apajasalo et al., 1998).  More 
specifically, they found that adult patients reported more problems for dimensions of 
usual activities and sexual activity, whereas adolescents had more problems with school, 
hobbies, and friends and were more concerned with their physical appearance.  Short 
stature is common among most, if not all, skeletal dysplasias, and it commonly has a 
negative impact on functioning.  Studies show that short stature impacts development and 
psychosocial functioning, increasing the risk for psychosocial problems (Abe et al., 2009; 
Magnusson et al., 2005).  Psychosocial effects that have been documented include 
negative comparisons with peers, social stigmatization due to height-related perceptions, 
social exclusion, and bullying at school (Harter, 2001; Sandberg & Colsman, 2005; 
Sandberg & Voss, 2002) 
HIV/AIDS is another condition that is highly associated with stigma.  HIV is a 
virus that attacks the body’s immune system, which ultimately leads to the inability to 
fight off infections and disease (Centers for Disease Control and Prevention [CDC], 
2010).  The virus is spread only through certain body fluids, such as blood, semen, 
preseminal fluid, rectal fluids, vaginal fluids, and breast milk (CDC, 2010).  HIV-related 
stigma occurs as a result of negative attitudes associated with behaviors linked to HIV 
transmission, such as homosexual sex or injectable drug use (Herek, 1999).  Research on 
the impact of HIV-related stigma is extensive.  The most commonly found associations 
are increased feelings of despair and depression, decreased self-esteem, and increased 
mental health problems (Berger, Ferrans, & Lashley, 2001; Buseh & Stevents, 2006; 
Mak, Poon, Pun, & Cheung, 2007).  Researchers have found that the psychological well-
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being of people with HIV is both a consequence and a predictor of perceived HIV stigma 
(Miller et al., 2017).  The experience of stigma within a healthcare setting has been found 
to negatively impact health-related behaviors, such as accessing testing and treatment and 
adherence to medical regimens (Butt, 2008; Fortenberry et al., 2002).  Furthermore, 
because psychological symptoms such as depression and other types of mental illness are 
risk factors for acquiring HIV, these individuals may be susceptible to stigmatization 
(Miller et al., 2017).   
Although many signs of HIV can go unnoticed, there are some symptoms of early 
and latent HIV that can be visible.  These include a maculopapular rash (red bumps on a 
flat, red patch of skin), skin lesions and thrush (yeast infection around the mouth), and 
enlarged lymph nodes.  There are also physical side effects of treatment, such as visible 
redistribution of body fat and/or localized fat loss around the buttocks, legs, arms, or face 
(Carr et al., 2003; Tien & Grunfeld, 2004).  These physical manifestations may intensify 
the level of experienced stigma.  In a study of people living with HIV comparing a group 
who could conceal their HIV versus those who could not, people with visible signs of 
HIV experienced more psychological distress and had lower self-esteem and reported less 
social support than those who could conceal their HIV status (Stutterheim et al., 2011).  
These findings were supported by a similar study in 2013 of the role of visible symptoms 
in HIV-related stigma.  Researchers found that individuals with visible symptoms 
experienced more HIV-related stigma and had poorer outcomes on a range of 
psychological and mental health measures than those who were able to conceal their 
disease (Brener, Callander, Slavin, & de Wit, 2013).   
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In summary, it is clear that conditions involving visible symptoms have a great 
impact on well-being and psychological adjustment.  Specifically, these symptoms often 
result in experiences of social stigmatization.  Because stigma leads to social 
marginalization and resultant stress, it is important to screen individuals with NF1 for 
level of perceived stigmatization.  Due to the nature of NF1 (abnormal physical 
appearance and characteristics), stigmatization may be a common and serious concern. 
Measures of Perceived Visibility and Stigmatization 
 Measures of perceived visibility specific to individuals with NF1 are scarce.  
Specific to NF, there are currently only two measures of disease severity and disease 
visibility, the Riccardi Scale and the Ablon Scale.  The Riccardi scale was developed to 
evaluate the severity of the disease (Riccardi & Kleiner, 1977).  This instrument yields a 
single score and can be completed by patients, clinicians, or researchers using medical 
files.  Grades of severity range from 1 to 4, in which 1 is minimal NF or few features of 
NF and 4 is severe NF or the presence of serious compromise.   
  The Ablon scale was developed to evaluate the visibility of the disease (Ablon, 
1996).  The ratings are based on appearance of the individual fully dressed and how 
readily physical symptoms could be perceived in impersonal interactions.  This 
instrument is measured on a 3-point scale, in which 1 is no visible tumors with normal 
gait and posture and 3 is numerous tumors on the face, optic glioma, and severe skeletal 
features.  Granstrom et al.  (2012) developed a scale of four items for patients to self-
assess whether their disease was visible to others when fully dressed.  The scale measures 
subjective, perceived visibility on a scale from 0 (not visible) to 4 (highly visible).  This 
scale is considered reliable and has a Cronbach’s alpha of 0.85 (Granstrom et al., 2012).  
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For the purpose of this current study, researchers wanted to measure participants’ 
perceived visibility of the condition using the 3-point Ablon scale.  Additionally, 
researchers wanted to get a measure of perceived stigmatization as it relates to their 
reported disease visibility.   
The Perceived Stigmatization Questionnaire (PSQ) is a 21-item, 3-factor measure.  
It measures the frequency of various stigmatizing social behaviors experienced by people 
with physical distinctions (Lawrence et al., 2006).  The PSQ was originally validated in a 
sample of long-term adult burn survivors (Lawrence et al., 2006).  The three factors are: 
absence of friendly behavior, confused and staring behavior, and hostile behavior 
(Lawrence, Rosenberg, Mason, & Fauerbach, 2011). 
Underlying Mechanisms of Perceived Visibility and Stigmatization 
Individuals with NF1 experience the condition in different ways.  Visibility of 
NF1 varies among cases, as does patient perception of these symptoms.  Research has 
illustrated the detrimental impact that may result from living with NF1, indicating the 
need for effective interventions to help many patients cope with appearance-related 
difficulties and accompanying patterns of psychological distress and problematic social 
interactions (Smith, Wang, Plotkin, & Park, 2013).  Similarly, level of perceived 
stigmatization also varies across cases.  To date, there is little research exploring the 
underlying cognitive factors that may influence or directly impact perceptions of NF1 
symptoms and related stigmatization, which may aid in guiding psychological 
interventions.  Because NF1 is highly comorbid with a variety of psychiatric and 
emotional concerns and cognitive distortions correlate with such mental disorders (e.g., 
Rosenfield, 2004), cognitive distortions are very relevant in this population.  Cognitive 
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distortions are a construct that stems from the cognitive model and the work of Aaron 
Beck.  It is important to understand the history of cognitive therapy and the development 
of cognitive distortions in order to fully explore their relevance in regard to NF1.   
Overview of Cognitive Therapy 
Cognitive therapy was developed in the late 1960s as a response to objections to 
the psychoanalytic model, the inability of behavior therapy to account for the cognitive 
processes of human behavior, and the growing demands of both the public and managed 
care for brief, effective treatment (Beck, 1976; Dobson & Dozois, 2001).  Many 
behaviorists of that era realized that their approach needed to expand beyond pure black-
box operant and classical conditioning models to account for the growing evidence for 
human cognitive processes (Hayes et al., 2005).  This set the stage for basic cognitive 
models as a logical alternative.   
Albert Ellis and Aaron Beck played a large role in incorporating cognitive aspects 
into the field of psychology.  Albert Ellis began to focus on the cognitive contribution to 
human dysfunction by distinguishing healthy from unhealthy feelings and rational from 
irrational thinking (Backx, 2011).  Ellis (1962, 1977) founded rational emotive therapy 
that proposed that the way people think makes them feel and behave in a certain way.  
His formulation opposed psychoanalytic insights and influence (Backx, 2011).  In 
contrast, Aaron Beck’s cognitive therapy model (Beck, 1967; 1976) incorporated 
psychoanalytic influence, which made it less challenging for long-standing 
psychoanalysts to make the “revolutionary step” towards the cognitive model (Backx, 
2011, p.  268).  Despite this difference, both models were based on the concept that 
irrational beliefs were the source of emotional distress or the cause of dysfunctional 
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behavior.  Summarized in short by Forman and Herbert (2009), cognitive behavior 
therapy is a collaborative, short-term treatment that uses both behavioral and cognitive 
strategies to alleviate distress. 
Meta-analyses show cognitive behavioral therapy (CBT) to be effective in the 
treatment of a variety of disorders.   Studies indicate that CBT is a highly effective 
treatment model for adult unipolar depression, adolescent unipolar depression, 
generalized anxiety disorder, panic disorder with or without agoraphobia, social phobia, 
posttraumatic stress disorder, and childhood depressive and anxiety disorders (e.g., 
Butler, Chapman, Forman, & Beck, 2006).  Support for CBT as an effective intervention 
for health anxiety, or hypochondriasis, has also been documented in a recent meta-
analysis (Cooper, Gregory, Walker, Lambe, & Salkovskis, 2017).  These findings are 
supported by Olatunji et al.  (2014), who found that CBT for health anxiety outperformed 
control conditions at posttreatment and follow up.  CBT also has shown promising results 
as an adjunct to pharmacotherapy in the treatment of schizophrenia and large 
improvements in the symptoms of bulimia nervosa (Butler et al., 2006).  Similarly, in a 
meta-analysis of CBT for adult depression, researchers found that combined treatment of 
CBT and pharmacotherapy is significantly more effective than pharmacotherapy alone 
(Cuijpers et al., 2013).   
The efficacy of CBT in adults with substance abuse disorder has also been well 
documented.  Hofmann et al.  (2012) conducted a review of 106 meta-analytic studies 
examining the efficacy of CBT across a variety of psychiatric conditions, including 
substance use disorder.  Their review found support for the efficacy of CBT among adults 
with cannabis dependence, and this efficacy increased with more sessions.  These 
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findings are supported by Magill and Ray (2009), who conducted a meta-analytic review 
of 52 studies that used CBT to treat adult alcohol and drug users.  They found that 29% 
of patients who received CBT had better outcomes than the typical person who did not 
receive any treatment.  These effects were strongest for women and for cannabis users.  
In regard to adolescents and substance use, Macgowan and Engle (2010) found that CBT 
effectively reduced alcohol and other drug use over time.  It may be such an effective 
mechanism of change partly because of the skills that are taught in CBT (Waldron & 
Kaminer, 2004). 
From a behavioral health and integrated care perspective, cognitive behavioral 
therapy shows great promise.  Due to the brief nature of CBT interventions and the 
impetus to improve evidence-based treatments for mental health conditions, there is 
benefit to utilizing this treatment within primary care.  In a study investigating the 
effectiveness of a CBT and mindfulness group for patients with mood and anxiety 
disorders within primary care, participation in a brief, evidence-based treatment group 
was associated with a statistically significant decrease, with large effect sizes for both 
depression and anxiety symptoms (Craner, Sawchuk, & Smyth, 2016).  Furthermore, 
65% of the participants enrolled in the group completed at least four sessions, which 
supports the feasibility of group treatment in primary care.   
Meta-analyses have also explored the long term effect of CBT interventions.  
Findings strongly suggest that across many disorders the effects of cognitive therapy are 
maintained for substantial periods beyond treatment.  Significant evidence for long-term 
effectiveness was found for depression, generalized anxiety, panic, social phobia, 
obsessive-compulsive disorder, sexual offending, schizophrenia, and childhood 
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internalizing disorders (Butler et al., 2006).  In a recent study, researchers found that CBT 
is effective in decreasing relapse rate and improving depressive symptoms, mania 
severity, and psychosocial functioning, with a mild-to-moderate effect size (Chiang et al., 
2017).   
Beck’s Model of Cognitive Therapy 
Beck’s cognitive therapy is the most prominent model of CBT.  Beck began his 
psychiatric training as a classic Freudian psychoanalyst and studied depression and anger 
(Beck & Weishaar, 1989).  His original belief was that “melancholia” was explained as 
anger directed inward (Roberts, 2015).   However, his own research found no support for 
this psychodynamic approach, but rather that individuals experienced a sense of loss and 
had a need for acceptance (Beck & Weishaar, 1989).   
Beck focused on the negative thoughts and distortions that were common among 
his depressed patients (Beck, 1976).  In looking at these patterns, Beck discovered the 
cognitive triad: negative view of the self, the world, and the future (Beck, 1976).  Beck’s 
model suggests that dysfunctional thinking regarding the cognitive triad is common to all 
emotional disorders or states of distress (Beck & Beck, 2011).  The conceptual 
framework of Beck’s cognitive therapy relies on the belief that early life experiences 
shape fundamental views of the self, world, and future (Beck, 1967).  These 
constellations of beliefs are known as schemas, which help individuals organize and 
perceive new information (Young, 1994).   Once these schemas are established, 
secondary beliefs develop and act as assumptions that are consistent with the cognitive 
triad (Beck et al., 1979).  Beck believed that negative schemas affected the encoding, 
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storage, and retrieval of information (Beck, 1967), and therefore cognitive distortions 
develop through the chain of schema and secondary assumptions (Roberts, 2015).   
Defining Cognitive Distortions 
 The concept of cognitive distortions was first proposed by Aaron T.  Beck (Beck, 
1976).  Cognitive distortions are defined as processing information in a predictable, 
problematic manner, resulting in identifiable errors of thinking (Beck, 1995).  The term 
cognitive distortions further refer to self-statements that are inaccurate or maladaptive 
and/or reflect a misinterpretation of events (Beck, 1995).  When faced with a cognitive 
distortion, individuals may act in accordance with the thought as they learn to treat the 
distortion as a rule to govern behavior.  Behaving in this way may lead to limited 
behavioral repertoire, increased emotional distress, and persistent maladaptive behavior 
(Torneke, Luciano, & Valdivia, 2008).   
 For those with a physical disease, cognitive distortions may play a role in personal 
perception of their condition.  For instance, this appears to be the case in disorders 
involving pain; cognitive responses, such as thoughts and beliefs, play a key role in the 
perception of pain and how people adjust to pain (Keefe et al., 2005).  According to Beck 
(1976), there is a systematic negative bias in the cognitive processing of patients who 
suffer from psychiatric disorders such as depression.  Norman, Miller, and Klee (1983) 
found that depressed subjects selected significantly more depressed distortions on the 
Cognitive Bias Questionnaire (Krantz & Hammen, 1979) than did non depressed 
subjects.   
Cognitive distortions take place in the domain of cognitive processes, which are 
the mechanisms by which an information processing system processes information over 
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time (Kendall, 1992).  If individuals process information based on a maladaptive schema 
or belief system, rather than accurate perceptions and interpretations of the environment, 
this may affect their overall level of adjustment, which may lead to emotional distress or 
disorder (Kendall, 1992).  When individuals process a distortion, they are actively 
processing information, but the thinking is misguided (Kendall, 1992).  Because 
emotional disorders stem from the presence of these dysfunctional distortions (Burns, 
1999), the goal of Beck’s cognitive therapy is to correct cognitive distortions and, 
ultimately, to alter maladaptive schemas and alleviate symptoms of emotional distress 
(Beck, 1979; J.  Beck, 2011; Roberts, 2015).   
Types of Cognitive Distortions 
From observed patterns of inaccurate reasoning among depressed individuals, 
Beck originally proposed six types of cognitive distortions (Beck & Weishaar, 1989): 
dichotomous thinking, arbitrary inference, magnification and minimization, 
overgeneralization, personalization, and selective abstraction (Beck & Weishaar, 1989).  
In 1999, Burns expanded Beck’s original list to ten cognitive distortions.  Burns’ 
Checklist of Cognitive Distortions consists of all-or-nothing thinking, discounting the 
positive, emotional reasoning, jumping to conclusions, labeling, magnification, mental 
filter, overgeneralization, blaming and personalization, and should-statements (Burns, 
1999).  Following Burns, Freeman and DeWolf (1992) and Freeman and Oster (1992) 
proposed three additional distortions: comparison, externalization of self-worth, and 
perfectionism.   
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Cognitive Distortions in the Medical Setting 
 Cognitive distortions have been associated with both psychological and medical 
disorders.  In regards to the latter, research now shows that physical illnesses impact a 
state of mental health (Uhl, 2007).  Psychologists believe that patients should have the 
opportunity to address psychosocial problems related to their physical illness (Belar & 
Deardroff, 1995).  Specifically, clinical health psychologists are interested in the meaning 
that patients attach to their illness and aim to be aware of a patient’s worldview and 
cognitive style (Belar & Deardoff, 1995).  Research has identified a number of medical 
conditions in which cognitive distortions play a role in psychological functioning, 
including chronic pain, cardiac disease, chronic illness and obesity (Marlatt & Gordon, 
1985; Shnek, Irvine, Stewart, & Abbey, 2001; Smith, Christensen, Peck, & Ward, 1994;).   
 Chronic pain has been studied extensively in relation to cognition.  Physical 
limitations as a result of chronic pain have an adverse impact on a self-image (Eimer, 
1989).  Individuals often suffer from negative self-perception, patterns of self-defeating 
beliefs, and depression (Uhl, 2007).  In a longitudinal study of cognitive distortion and 
depression among individuals with chronic pain due to rheumatoid arthritis, researchers 
found that higher levels of cognitive distortion and perceived helplessness predicted 
higher levels of depressive symptoms over a 4-year span (Smith et al., 1994).  Among 
these same patients, those exhibiting tendencies to overgeneralization, selective 
abstraction, personalization, and catastrophizing were more vulnerable to depression than 
patients with an adaptive coping style (Smith et al., 1994).   
 Cognitive distortions have also been studied among individuals with diabetes.  
Using the Irrational Health Belief Scale (IHBS; Christensen, Moran, & Wiebe, 1999), 
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researchers found that higher scores on the IHBS had a significant correlation with 
objective measures of poor diabetes management (Christensen et al., 1999).  This study 
indicates that cognitive distortions may play a role in health-related behavior, which in 
turn, may impact prognosis and health outcomes.  Individuals who are more likely to 
engage in negative health habits (as measured by the Millon Behavior Medicine 
Diagnostic) are more likely to engage in cognitive distortions (Uhl, 2007).   
Because clinically significant depressive symptoms among cardiac patients have 
been estimated to occur in 14% to 27% of heart patients (Shnek et al., 2001), cognitive 
distortions have been studied among these individuals.  Researchers who studied adults 
with a myocardial infarction or unstable angina found that higher levels of learned 
helplessness and cognitive distortions and lower levels of self-efficacy and optimism 
were significantly related to depressive symptoms at 1 month after hospital discharge and 
at 1 year follow-up (Shnek et al., 2001).  Despite these levels of cognitive distortions, the 
influence of cognitive distortions on depressive symptoms dissipated over time in 
comparison to the lower levels of optimism (Shnek et al., 2001).   
Individuals who are obese are considered to be at high risk for an array of 
psychological complications (Shook, 2010).  Researchers have found that binge eating is 
related to increased rates of depression among individuals who are obese (Stunkard, 
2002).  Additionally, individuals who are obese are at a significantly greater lifetime 
prevalence of Axis 1 disorders (Eldredge & Agras, 1996).  Given their rates of 
psychological distress, cognitive distortions were explored among those who are obese.  
In a study of 385 adults, Shook (2010) found that participants who engaged in more 
cognitive distortions were more likely to have a drug problem or eating problem.  
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Research shows that overeating may be related to cognitive distortions such as all-or-
nothing thinking, which are the distortions implicated in the high relapse rates by 
alcoholics and smokers (Marlatt & Gordon, 1985).    
In summary, research demonstrates that cognitive distortions play a major role in 
the lives of individuals affected by medical conditions.  However, to date, there is no 
research on cognitive distortions among the NF1 population.  As previous research 
indicates, depressed persons and those with various medical conditions have more 
cognitive distortions than those not meeting diagnostic criteria for such disorders 
(Hammen, 1978).  Because individuals with NF1 are at increased risk for depression 
(Cohen, 2015), a high frequency of cognitive distortions is likely among this population.  
Measuring and identifying such maladaptive thought processes associated with NF1 can 
help to guide treatment.   
Measuring Cognitive Distortions  
 Several self-report instruments have been developed for measuring cognitive 
distortions.  These measures include the Automatic Thoughts Questionnaire (ATQ; 
Hollon & Kendall, 1980), the Cognitive Errors Questionnaire (CEQ; Lefebvre, 1981), the 
Cognitive Distortions Scale (CDS; Briere, 2001), the Dysfunctional Attitude Scale (DAS-
A, DAS-B; Weisman, 1979) and the Inventory of Cognitive Distortions (Yurica, 2002).   
 The Automatic Thoughts Questionnaire is a 30-item instrument designed to 
measure the frequency of automatic negative self-statements associated with depression, 
and differentiates between depressed and non-depressed individuals (Hollon & Kendall, 
1980).  It uses a Likert scale ranging from 1 (not at all) to 5 (all the time) and the total 
score is the sum of all 30 items (Hollon & Kendall, 1980).  It proves to have strong 
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internal reliability and concurrent validity and is useful as a measure of cognitive 
distortions related to depression (Hollon & Kendall, 1980).  The ATQ was revised in 
1989 and continued to differentiate depressed from non-depressed participants; however, 
it included positive and neutral self-statements in addition to the established negative 
self-statements (Kendall, Howard, & Hays, 1989).   
 The Cognitive Errors Questionnaire was developed to investigate the application 
of the cognitive theory of depression in depressed psychiatric patients, depressed low 
back pain patients, non-depressed low back pain patients, and non-depressed individuals 
without low back pain (Lefebvre, 1981).  It measures an overall level of cognitive 
distortions as well as four specific types of cognitive distortion: catastrophizing, 
overgeneralization, personalization, and selective abstraction (Lefebvre, 1981).   The 
CEQ is comprised of 24 vignettes.  Each vignette is followed by a negative thought about 
the vignette reflecting one of the four cognitive distortions.  Using a Likert scale ranging 
from 1 (almost exactly as I would think) to 5 (not at all as I would think), respondents are 
then asked to rate how likely they would be to react in a similar situation.  The CEQ has 
high test-retest reliability (.80 to .85), high alternate forms reliability (.76-.82), and high 
internal consistency reliability (.89 to .92).   
 The Cognitive Distortions Scale is a 40-item self-assessment of cognitive 
distortions for adults (Briere, 2000).  Specifically, the CDS is used to evaluate cognitive 
distortions in returning veterans with posttraumatic stress disorder (Owens, Chard, & 
Cox, 2008).  It has also been used to distinguish between female patients with dual 
diagnoses of PTSD and substance abuse disorder (Najavits, Gotthardt, Weiss, & Epstein, 
2004).  Respondents rate how often they have had different thoughts or feelings in the 
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last month, using a Likert scale ranging from 1 (never) to 5 (very often).  Internal 
consistency for the CDS was found to be strong, ranging from .89 to .97, and an overall 
mean alpha of .93. 
 The Dysfunctional Attitude Scale is also a 40-item scale that measures 
dysfunctional attitudes as they relate to depression (Weissman, 1979).  It includes single-
sentence items and measures seven value systems: approval, love, achievement, 
perfectionism, entitlement, omnipotence, and autonomy.  Respondents answer using a 
Likert scale ranging from 1 (totally agree) to 5 (totally disagree).  The instrument has 
high internal consistency (.84 to .92) and strong test-retest correlations (.80 to .84). 
Inventory of Cognitive Distortions 
 In order to quantify specific cognitive distortions, Yurica and DiTomasso 
developed the Inventory of Cognitive Distortions (ICD; Yurica, 2002).  Using cognitive 
distortions found in the literature, Yurica (2002) performed a factor analysis that revealed 
11 fundamental cognitive distortions, 10 of which closely resembled previously identified 
distortions.  One additional distortion, emotional reasoning and decision-making, was 
therefore included.  Among cognitive therapy experts, there was 100% independent 
agreement (Yurica, 2002).  These 11 distortions are: externalization of self-worth, 
fortune-telling, magnification, labeling, perfectionism, comparison to others, emotional 
reasoning, arbitrary inference/jumping to conclusions, minimization, mind-reading, and 
emotional reasoning and decision-making (Yurica, 2002).   
  The ICD is a valuable measure that has many advantages over other measures of 
cognitive distortions.  Previous instruments lack specificity in the terms used to describe 
cognitive distortions (Roberts, 2015).  The terms belief, schema, cognitive distortions, 
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thinking errors, and dysfunctional attitudes are used interchangeably (Weissman, 1979).  
Additionally, some of the previous measures of cognitive distortions, specifically the 
ATQ and the DAS, are limited in that they measure cognitive distortions specific to 
depression (Yurica, 2002).    
The ICD has been used in many studies, demonstrating good validity across 
different populations.  In a study investigating the relationship between cognitive 
distortions and Axis 1 and Axis II psychopathology, Rosenfield (2004) found that 
individuals who meet the criteria for almost any Axis I or Axis II disorder report a greater 
frequency of cognitive distortions, as measured by the ICD, than individuals who are 
subclinical.  Moreover, both the severity of pathology and the number of comorbidities 
on both clinical syndromes and personality disorders correlated with an increased 
frequency of cognitive distortions.   
Results of validity testing suggested the higher the endorsement of cognitive 
distortions, the higher the frequency of dysfunctional thinking and the greater the 
endorsement of depressive symptoms (Yurica, 2002).  Also, the ICD was able to 
distinguish between depressed and non-depressed individuals, as well as differentiate 
between individuals suffering from an anxiety disorder and individuals in a control group 
(Rupertus, 2004; Yurica, 2002).  Uhl (2007) used ICD to assess distortions in medical 
sample.  He found that the more frequently a patient engaged in cognitive distortions, the 
more likely they were to engage in negative psychological and health risk behaviors, such 
as the use of drugs, overeating, increased use of caffeine, being less active, and smoking.  
Also within a medical setting, the ICD was found to be useful in identifying the 
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relationship between patterns of unhealthy behavior and cognitive distortions in those 
individuals who are obese (Shook, 2010).   
Overall, the ICD has proved useful across a variety of populations and contexts.  
The instrument was able to differentiate individuals suffering from anxiety or depression 
and could predict unhealthy lifestyles in a sample of medical patients, by their level of 
cognitive distortion (Rosenfield, 2004; Rupertus, 2004; Shook, 2010; Uhl, 2007; Yurica, 
2002).  By using the ICD to measure cognitive distortions among the NF1 population, 
clinicians can determine if there is a need to address maladaptive thinking patterns in 
treatment.  In turn, such an increase in more rational thinking could aid in improving 
adaptive functioning, mood, and acceptance of the disorder.   
History of Acceptance  
In recent years, acceptance-based and mindfulness-based therapies have attracted 
a great deal of attention.  These therapies are part of an overarching family of cognitive 
and behavioral therapies (Forman & Herbert, 2009).  Mindfulness-based cognitive 
therapy originally derived from the Buddhist practice of mindfulness (Gordon, Griffiths, 
& Shonin, 2014).   Buddhism originated approximately 2,500 years ago and is based on 
the teachings of Siddarth Gautama (more recently known as Shakyamuni Buddha) 
(Gordon et al., 2014).  The three main principles of Buddhism, wisdom, meditation, and 
ethical awareness, are collectively known as the three trainings, which influenced 
Western psychology and interventions.   
In the 1980s, Jon Kabat-Zinn adopted the word mindfulness from its use in 
Western Buddhism (Kabat-Zinn, 1990).  He defined mindfulness as “paying attention in a 
particular way: on purpose, in the present moment, and nonjudgmentally” (Kabat-Zinn, 
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1994, p.  4).  In 1979, Zinn developed mindfulness-based stress reduction (MBSR), 
traditionally used for chronic pain (Kabat-Zinn, 1990).  At the same time, other writers 
were converging on practices similar to mindfulness (Dryden & Still, 2006).  Steven 
Hayes developed techniques for developing awareness and acceptance, in which he also 
acknowledged Buddhism (Hayes, 1984).  Hayes, well known for his development of 
acceptance and commitment therapy (ACT), proposes that these approaches are a new 
generation of cognitive behavior therapy.  The history of behavior therapy is generally 
regarded in three distinct waves: traditional behavior therapy, CBT, and a third 
generation of contextualistic approaches (Hayes, 2004).   
In the 1950s, the first generation of behavior therapy took an empirical, objective, 
scientific approach in response to the perceived shortcomings of psychoanalytic theory 
and as a result of the findings of the early behaviorists (Forman & Herbert, 2009).  
Existing clinical theories were vague and lacked scientific evidence (Hayes, 2004).  
Behaviorists aimed to modify problematic behavior and emotion through the application 
of classical and operant learning principles (Forman & Herbert, 2009).  Psychoanalytic 
clinicians, such as Freud, argued against this new approach, which became grounds for 
debate (Hayes, 2004).  Despite this new focus and shift away from analytic and 
humanistic concepts, proponents of behaviorism and clinicians recognized that behavioral 
principles needed to expand to include cognitive processes (Bandura, 1969).  This new 
insight led to the second generation of behavior therapy. 
The second wave of behavior therapy occurred in the late 1960s (Forman & 
Herbert, 2009).  Cognitive factors were now presumed to play an important role in an 
individual’s interpretation of, and emotional and behavioral response to environmental 
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stimuli (Bandura, 1969).  Several psychotherapies were developed, including rational 
emotive behavior therapy (Ellis, 1962), stress inoculation training (Meichenbaum & 
Deffenbacher, 1988), and cognitive therapy (Beck, 1979).  Proponents of these therapies 
believed that maladaptive thoughts, schemas, or information-processing styles were 
responsible for distress and negative behavior (Forman & Herbert, 2009).   
The third wave of behavior therapy began to arise in the 1990s (Forman & 
Herbert, 2009).  Examples of third wave interventions include dialectical behavior 
therapy (Linehan, 1993), mindfulness-based cognitive therapy (Segal, Williams & 
Teasdale, 2002), meta-cognitive approaches (Wells, 2007), and ACT (Hayes et al., 1999).  
For many, ACT is strikingly similar to CBT and is debated as being an entirely new 
treatment approach; however, there are subtle differences that should be noted.  There is a 
critical difference between ACT and CBT in the way each therapy addresses cognitions.  
Whereas CBT distinguishes actions, emotions, and cognitions as separate entities, ACT 
includes cognitions under the term behavior.  Therefore, the word cognition has a 
different meaning in ACT than in CBT (Hofmann & Asmundson, 2008).  These two 
modalities also differ in regards to the role of emotions.  Although they share many of the 
same techniques to reduce emotional distress, they differ in specific emotional regulation 
strategies.  ACT targets experiential avoidance and the attempts to manage unpleasant 
emotions through suppression and other dysfunctional emotion regulation strategies 
(Hofmann & Asmundson, 2008).  In contrast, CBT focuses on the situation that generates 
the emotional experience.  In sum, ACT counteracts response-focused emotional 
regulation strategies, whereas CBT promotes adaptive antecedent-focused emotion 
regulation strategies (Hofmann & Asmundson, 2008).  Although these differences 
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between ACT and CBT do exist, there is great overlap in these two modalities of 
treatment.  A thorough literary review resulted in no research specifically investigating 
the direct relationship between cognitive distortions and acceptance.  For the purpose of 
this study, a more exhaustive history of ACT will be provided.   
Acceptance and Commitment Therapy 
 ACT is based on the theory of functional contextualism (Biglan & Hayes, 1996).  
Contextualism views psychological events as ongoing actions of the whole organism 
interacting with historically and situationally defined contexts (Hayes et al., 2006).  The 
core components of functional contextualism are: “(a) focus on the whole event (b) 
sensitivity to the role of context in understanding the nature and function of an event (c) 
emphasis on a pragmatic truth criterion, and (d) specific scientific goals against which to 
apply that truth criterion” (Hayes, 2004, p.  646).  Within ACT, there is a conscious 
openness and acceptance to all psychological events, even if they are previously negative, 
irrational, or psychotic (Hayes, 2004, p.  647).  From this perspective, behavioral events 
are interpreted as ongoing acts within their current and historical context (Yu & 
McCracken, 2016).  ACT does not focus on creating change in the content of thoughts 
and feelings, but instead to alter their function, or change the individual’s “relationship 
with” thoughts or feelings (Yu & McCracken, 2016, p.  12).  This gives the individual 
more behavioral choices in which to engage (Yu & McCracken, 2016).    
ACT therapeutic approaches emerged from a behavioral theory known as 
relational frame theory.  Relational frame theory states that the core of human language 
and cognition is the ability to relate events under arbitrary contextual control (Hayes, 
2004); in short, it is necessary to analyze cognition in order to understand human 
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behavior.  From this standpoint, a primary source of psychopathology is the way that 
language and cognition interact with contingencies to produce an inability to persist in or 
change behavior (Hayes et al., 2006).  This inability to change behavior or persist, termed 
psychological inflexibility, develops from weak contextual control over language 
processes (Hayes et al., 2006).  The goal of ACT is psychological flexibility: being able 
to contact the moment as a conscious human being more fully, based on what the 
situation offers, and persisting based on chosen values (Hayes et al., 2013).  The terms 
psychological flexibility and psychological inflexibility are similar to those of acceptance 
and experimental avoidance (Wolgast, 2014).  Experimental avoidance, in ACT, refers to 
the unwillingness to remain in contact with aversive private experiences and taking action 
to avoid and/or alter them (Hayes et al., 1996).  In contrast to experimental avoidance is 
the construct of acceptance, the willingness to experience unwanted private events 
(Hayes et al., 2006).  There are six processes within the ACT model in order to establish 
psychological flexibility: acceptance, cognitive diffusion, the now, self, values, and 
committed action (Hayes et al., 2013).   
Acceptance Defined 
 Acceptance involves the active and aware embrace of private events without 
unnecessary attempts to change their frequency or form (Hayes et al., 2006).  Research 
shows that acceptance interventions alone, and in combination with other ACT 
components, increase persistence and willingness to engage in distressing tasks (Hayes, 
Bissett, et al., 1999).  However, acceptance is not merely tolerance, it is the active 
nonjudgmental embracing of experience in the here and now (Hayes, 2004).  In ACT, 
acceptance is not possible without cognitive diffusion, which can be defined as changing 
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the way one interacts with or relates to thoughts (Hayes et al., 2006).  Acceptance 
inherently involves exposure, in which an individual experiences an event actively and 
fully in the present, moment by moment, for the sole purpose of experiencing actively 
and fully (Hayes, 2004).  For individuals experiencing either a physical or psychological 
disorder, it may be a challenge to practice the act of acceptance.  Cognitive resources 
may be limited among these individuals, making it more challenging to relate to their 
thoughts in a new way.  Furthermore, coping with physical limitations may make it 
difficult to focus on the present moment if considering the course of their disorder and 
future complications.  Therefore, the construct of acceptance is worth measuring in NF1 
individuals, who present with both physical and psychological complications, in order to 
help guide therapeutic treatment and increase psychological flexibility. 
Measuring Acceptance 
 Measures of acceptance are often called measures of psychological flexibility or 
experiential avoidance.  Hayes et al.  (2004) first proposed the importance of establishing 
a measure of experiential avoidance for population-based studies, as the construct was 
implicated in a wide range of clinical problems and disorders from substance abuse to 
suicide (Hayes et al., 2004).  Hayes acknowledged the success of other researchers who 
had established measures of avoidance of specific thoughts and feelings involved in a 
particular clinical problem.  For example, he credits McCracken (1998) for developing a 
measure of avoidance of pain and Gifford (2002) for developing a measure of avoidance 
of thoughts associated with smoking cessation.  It was during that time, Hayes and 
coworkers (2004) developed the first version of the Acceptance and Action Questionnaire 
(AAQ), a 32-item measure designed to assess a high need for emotional and cognitive 
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control, avoidance of negative private events, and the inability to take needed action in 
the face of these events.  Over time, measures of acceptance have been adapted and 
modified to address specific disorders or concerns.  However, because a specific 
acceptance measure has not yet been created for experiences related to NF1, for the 
purpose of this study, a more generalized measure of psychological flexibility will be 
utilized.   
 The Acceptance and Action Questionnaire (AAQ) is the most widely used 
measure of experiential avoidance and psychological inflexibility (Bond et al., 2011).  
The original scale included 9 to 16 items and was a Likert-type scale.  The scale 
contained items on negative evaluations of feelings, avoidance of thoughts and feelings, 
distinguishing a thought from its referent, and behavioral adjustment in the presence of 
difficult thoughts or feelings (Bond et al., 2011).    
 The AAQ has proven to be useful and has led to a number of versions.  A meta-
analysis of the AAQ found that it predicted a variety of quality of life outcomes, such as 
psychopathology, stress, pain, job performance, and negative affectivity (Hayes et al., 
2006).  As use of the measure began to grow, a number of versions were tailored to 
particular areas or populations, such as pain (McCracken, Vowles, & Eccleston, 2004), 
smoking (Gifford et al., 2004), diabetes management (Gregg, Callaghan, Hayes, & 
Glenn-Lawson, 2007), tinnitus (Westin, Anderson, & Hayes, 2008), weight-related 
difficulties (Lillis & Hayes, 2008), and coping with epilepsy (Lundgren, Dahl, & Hayes, 
2008).  Although the AAQ is widely used, there are documented concerns regarding the 
internal consistency.  In a validation study by Hayes et al.  (2004), the alpha coefficient 
was only .70, and its test-retest reliability was .64 over 4 months.  These low alpha levels 
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are consistent and may be due to the complexities of individual items (Bond et al., 2011).  
The AAQII was developed in response to the shortcomings of the AAQI, as a 
measurement of psychological inflexibility. 
 Acceptance in Health Care 
The construct of acceptance and the efficacy of ACT have been studied among a 
variety of disorders in health care.  ACT has been explored in treating various mental 
health conditions, anxiety, and body image.   
Mental health disorders. 
 There is now accumulating evidence for the effectiveness of ACT across a variety 
of mental health conditions (Yu & McCracken, 2016).  In a meta-analysis of 18 
randomized controlled trials in which ACT was compared to inactive control conditions 
and established treatments, an overall advantage was found for ACT; the average ACT-
treated participant had greater improvement than 66% of the participants in the control 
group (Yu & McCracken, 2016).  In exploring the effectiveness of ACT within the field 
of mental health, we will consider its effect on conditions such as depression, anxiety, 
and body image.  Although this list is not exhaustive, it provides insight into the 
usefulness and promise of ACT as an intervention.   
 A meta-analysis found that ACT demonstrated moderate group and 
pretreatment/posttreatment effects for symptom reductions for anxiety and depression 
(Hacker, Stone, & MacBeth, 2016).  Despite these results, the researchers acknowledged 
that ACT may not be more effective than traditional treatment approaches, and further 
inquiry was warranted.  In a separate meta-analytic review of studies examining the 
relationships between the core ACT process of change (psychological flexibility) and 
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anxiety symptomatology, results showed a positive and significant relationship between 
the AAQ scores and general measures of anxiety and specific measures of disorder 
severity (Bluett, Homan, Morrison, Levin, & Twohig, 2014).  This indicates that a higher 
level of inflexibility correlates with anxiety.  Further exploration found that mindfulness 
meditation (an ACT technique) was associated with statistically significant improvement 
in depression, physical health-related quality of life, and mental health-related quality of 
life (Hilton et al., 2017) 
 Acceptance has also been investigated in regards to body image.  Body image is 
an important aspect in which individuals evaluate themselves and estimate their social 
rank and is very relevant to the current study (Gilbert, 2002).  In the general and clinical 
populations, body dissatisfaction (BD) is highly prevalent, for example, affecting more 
than 80% of women (Mond et al., 2013).  BD has been found to be an important risk 
factor for disordered eating behaviors, such as rigid dietary restraint and bulimic 
behaviors (Anton, Perri, & Riley, 2000).  Research also shows that body dissatisfaction 
can negatively affect quality of life in various domains, specifically psychosocial 
functioning and mental health (Liimakka, 2014; Mond et al., 2013).  When considering 
ACT for body image, rather than attempting to change the content of distressing body 
image-related cognitions and emotions themselves, an alternative ACT approach is to 
focus on the relationship with these experiences (Lee, Smith, Twohig, Lensegrav-Benson, 
& Quakenbush-Roberts, 2017) by using body image flexibility, which is the ability to 
openly experience body image dissatisfaction and related experiences in a way that 
promotes adaptive life functioning and values-consistent behavior (Sandoz, Wilson, 
Merwin, & Kellum, 2013).   
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 Body image flexibility shares conceptual foundations with ACT’s psychological 
flexibility construct as applied to the context of body image (Sandoz et al., 2013).  It 
shares elements of a positive rational acceptance style in coping with body image-related 
stressors (Cash et al., 2005).  Specifically, body image flexibility involves openly 
engaging painful or unwanted thoughts and emotions regarding body size, shape, or 
weight with mindful acceptance (Sandoz et al., 2013). 
 Body image flexibility has been assessed using the Body Image Acceptance and 
Action Questionnaire (BI-AAQ; Sandoz et al., 2013).  The BI-AAQ is a domain-specific 
measure of psychological flexibility, based on the more general measure of psychological 
inflexibility, the Acceptance and Action Questionnaire-II.  Although acceptance in 
relationship to the construct of body image is often studied among those with eating 
disorders, it can be generalized to all individuals experiencing body-image distress.   
Physical Disorders.   
 ACT has been applied both to mental health concerns and physical disorders and 
complications, as well.  The most commonly explored physical condition in which ACT 
has been applied is chronic pain.   
The construct of acceptance has been extensively studied among individuals 
experiencing chronic pain.  In this context, acceptance is conceptualized as an underlying 
psychological state of willingness to experience pain and its cognitive and emotional 
facets while continuing to live life as normally as possible (Reneman, Dijkstra, Geertzen, 
& Dijkstra, 2010).  ACT for chronic pain involves identifying helpful ways to respond to 
thoughts and feelings, exploring values, and developing mindfulness skills (Baranoff, 
2016).  The goal of ACT is not to eliminate pain, but to change the relationship with pain 
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so that pain is not the defining feature of life.  This shift in perspective resulting from the 
aforementioned ACT processes ultimately helps the person to accept the experience of 
pain, refocus to values and goals and, ultimately, to achieve and maintain a higher QOL 
(McCracken & Eccleston, 2003). 
In studies of chronic pain, acceptance has been defined as being comprised of two 
factors: activity engagement (a commitment to engaging in valued activities even in the 
face of illness related symptoms) and willingness (a willingness to experience sometimes 
painful or aversive symptoms if it means being able to participate in valued life activities) 
(McCracken, 2010).  Activity engagement and willingness factors of chronic pain 
acceptance are strongly associated with key predictors of medical, behavioral, 
psychosocial, and functional outcomes (McCracken and Velleman, 2010).  Research also 
shows that acceptance is associated with higher quality of life in patients with low back 
pain, a decrease in the impact of pain flares in patients with rheumatoid arthritis, and 
adaptive functioning in patients with mixed pain conditions (Dahl, 2009; McCracken, 
2007; Vowles et al., 2008) 
Recently, mindfulness has also been determined to be a key mediator between 
pain experiences and outcome (Hofmann et al., 2010).  The effectiveness of mindfulness-
based processes for medical conditions with chronic pain has been shown in symptom 
reduction and improvement of emotional well-being (Baer, 2003).  A meta-analysis of 30 
randomized controlled trials found that mindfulness meditation was associated with a 
small effect of improved pain symptoms, compared with treatment as usual and 
educational support groups (Hilton et al., 2017.)  
COGNITIVE DISTORTIONS AND NF1   49 
Many clinical manifestations of NF1 are associated with pain, making the 
disorder a potential candidate for ACT research and treatment.  For instance, cutaneous 
neurofibromas are sometimes painful as they first develop, and plexiform neurofibromas 
sometimes produce nerve root pain (Tonsgard, 2006; Tucker et al., 2009).  Malignant 
peripheral nerve sheath tumors (MPNSTs) are often associated with significant pain 
(Crawford et al., 2015; Tonsgard, 2006).  Among the 60 Australian adults with NF1, one 
quarter of participants reported pain (Crawford et al., 2015).  With the exception of pain 
associated with MPNSTs, the source of pain is often benign, varies in its origin, and is 
difficult to treat (Crawford et al., 2015).  Headaches, back pain, orthopedic problems, and 
gastrointestinal complications are also common symptoms of NF1 that result in chronic 
pain (Oates et al., 2013; Tonsgard, 2006).  Despite the pain that is often associated with 
the disorder, research on acceptance among those with NF1 is limited.   
Overall, research indicates that ACT is effective for individuals with various types 
of pain.  However, despite reports of pain, NF1 is distinct from these other conditions 
because many individuals with NF1 have comorbid learning and attention problems.  
Within the context of therapy, these cognitive deficits could make therapeutic 
interventions more challenging, if the individual has difficulty focusing in session or 
following through on therapeutic homework.   
To date, there is little research exploring acceptance among adults with NF1.  In a 
pilot study examining the effectiveness of ACT among youth with NF1, researchers 
found that ACT interventions resulted in less pain interference and lower patient-reported 
pain in follow-up data (Martin et al., 2016).  Pain interference in this study was defined 
as “how much the pain has interfered with sleep, mood, social activities, etc.  in the past 
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two weeks” (Martin et al., 2016, p.  1465).  These preliminary results suggest that ACT 
may be an effective tool for decreasing pain among those with NF1.  There is currently 
an ongoing clinical trial that is examining the efficacy of ACT among individuals with 
NF1 (National Cancer Institute, 2017).  More investigations on the feasibility and 
efficacy of ACT within this population are needed (Martin et al., 2016).   
Purpose of the Study 
 The purpose of this study was to explore the relationship between cognitive 
distortions, perceived stigmatization, and acceptance among adults with NF1.  
Understanding how cognitive distortions and perceived stigmatization impact levels of 
acceptance may permit clinicians to tailor treatment to address these specific maladaptive 
thinking patterns.  If cognitive distortions predict levels of perceived stigmatization (and 
the accompanying dysphoria and dysfunction) clinicians may be able to make therapeutic 
interventions more efficient by focusing on ameliorating those cognitive mechanisms.  
Treatment can then focus on increasing acceptance and improving functioning for 
individuals with this disorder.  
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Chapter 3: Research Hypotheses 
H1: The frequency of cognitive distortions and level of perceived stigmatization 
will predict the level of acceptance among adults with NF1.  Frequency of cognitive 
distortions will be operationalized as total scores on the Inventory of Cognitive 
Distortions; level of perceived stigmatization will be operationalized as scores on the 
Perceived Stigmatization Questionnaire; level of acceptance will be operationalized as 
scores on the Acceptance and Action Questionnaire II. 
H2: The frequency of cognitive distortions and rating of disease visibility will predict the 
level of perceived stigmatization among adults with NF1.  Frequency of cognitive 
distortions will be operationalized as total scores on the Inventory of Cognitive 
Distortions; disease visibility will be operationalized as the score on the Ablon scale; 
level of perceived stigmatization will be operationalized as scores on the Perceived 
Stigmatization Questionnaire. 
H3: The age at NF1 diagnosis will predict the level of acceptance among adults with NF1.  
Age at diagnosis will be collected via the demographic questionnaire; level of acceptance 
will be operationalized as scores on the Acceptance and Action Questionnaire II. 
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Chapter 4: Method 
Research Design 
This study employed a cross-sectional, correlational design.  Data was collected 
via online survey.   
Participants and Recruitment  
Participants were recruited online through five national NF organizations.  This 
was done by providing a recruitment message to each organization to advertise this study 
via their listservs or websites.  These organizations were: 
§ Neurofibromatosis Network, a national organization that advocates for NF 
research and federal funding.  They offer access to clinical studies and support 
groups for those with NF.   
§ Children’s Tumor Foundation (CTF), a funder of scientific research.  Over 70% 
of all data on NF has been research funded or co-funded by the CTF.   
§ National Organization for Rare Disorders, a coalition formed to help advocate for 
individuals with rare diseases including NF and to advance medical research.   
§ Johns Hopkins Comprehensive Neurofibromatosis Center, part of a national 
collaboration of medical centers providing and managing care for those with NF.  
They are affiliated with the Children’s Tumor Foundation providing access for 
families and individuals coping with the disorder.   
§ Neurofibromatosis Therapeutic Acceleration Program, a program focused 
exclusively on improving treatment options for people with NF1.  In addition to 
the aforementioned formal organizations, participants were recruited via 
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Facebook, other social media networks via snowball sampling, and word of 
mouth.   
Inclusion and Exclusion Criteria 
Eligible participants were between the ages of 18 and 65.  Participants reported 
having been diagnosed with NF1 by a physician at some time in their life.  They must 
have reported having access to the internet, being fluent in English, and at least an eighth-
grade education.   
Participants were excluded if they reported that they were not between the ages of 
18 and 65, did not have access to the internet, or were not fluent in English.  They were 
also excluded from the study if they did not have at least an eighth-grade education or if 
they had a previous diagnosis of intellectual disability or endorsed current psychotic 
symptoms. 
Measures 
 For the purpose of this study, a screening questionnaire (Appendix A) was 
administered to determine eligibility.  A demographic questionnaire (Appendix B) was 
administered to all qualifying participants.  Following completion of these questionnaires, 
four brief measures were utilized: Inventory of Cognitive Distortions (ICD), Ablon scale, 
the Perceived Stigmatization Questionnaire (PSQ), and Acceptance and Action 
Questionnaire.  Reported completion times for each measure are: Inventory of Cognitive 
Distortions approximately 20 to 25 minutes, Ablon scale approximately 5 minutes, 
Perceived Stigmatization scale approximately 10 to 15 minutes, and Acceptance and 
Action Questionnaire approximately 5 minutes.   
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Inventory of Cognitive Distortions (Yurica, 2002).  The Inventory of Cognitive 
Distortions is a 69-item self-report measure comprised of various statements reflecting 11 
different cognitive distortions.  The ICD items are scored on a Likert scale ranging from 
1 (never) to 5 (always) which reflects a respondent’s level of agreement to each 
statement.  The total score is calculated and ranges from 69 to 345, in which higher 
scores indicate greater endorsement of cognitive distortions (Yurica, 2002).   
Psychometric evaluation of the ICD reflects strong internal consistency and test-
retest reliability.  In regards to internal consistently, Cronbach’s alphas have ranged from 
.97 to .98 (Roberts, 2015; Rosenfield, 2008; Yurica 2002).   In regards to test-retest 
reliability, following a 5-week interval, reliability was also found to have a high 
reliability coefficient (.998);  (Yurica, 2002).  This measure has also been positively 
correlated with accepted measure of depression demonstrating good validity.  The ICD 
correlates strongly with similar measures of dysfunctional thinking, anxiety, and 
depression, suggesting strong concurrent validity; positive correlations have been 
documented with the Dysfunctional Attitudes Scale (r = .70), the Beck Depression 
Inventory II (r = .70), and the Beck Anxiety Inventory (r = .59) (Roberts, 2015; Yurica, 
2002).   
Ablon scale (Ablon, 1996).  The Ablon scale is a measure used to evaluate the 
visibility of the disease.  Ratings can be completed by the patient or an observer; 
however, for the purpose of this study, the patients completed this scale in regards to their 
own appearance.  Ratings are based on appearance of the NF1 individual when fully 
dressed and how readily symptoms could be perceived in impersonal interaction.  This 
instrument is scored on a 3-point scale.  The individual with NF1 is assigned a single 
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qualitative score of either 1 (mild), no visible tumors with normal gait and posture; 2 
(moderate), Some tumors on neck, face, hands, and mild scoliosis or other skeletal 
feature without noticeable limp; or 3 (severe), numerous tumors on the face, optic glioma 
that affect sight and eye socket, and severe skeletal features with noticeable limp.  There 
are currently no documented psychometric properties for the Ablon scale; however, it has 
been adopted and used by many researchers, specifically in studies of quality of life.  The 
widespread use of this measure indicates good clinical utility.   
Perceived Stigmatization Questionnaire (Lawrence et al., 2010).  The PSQ is a 
21-item, 3-factor measure of perceived stigmatization.  It measures the frequency of 
various stigmatizing social behaviors that have been experienced by people with physical 
distinctions.  The items are scored on a Likert scale ranging from 1 (never) to 5 (always).  
Total scores range from 21 to 105.  Higher scores indicate higher levels of perceived 
stigmatizing behaviors.  Psychometric analyses show that the Cronbach’s alpha on the 
PSQ total score was .86 among children and .89 among adults.  Cronbach’s alpha on the 
PSQ subscales ranged from .79 to .81 in the child sample and .82 to .86 in the adult 
sample.  The three subscales of the PSQ, used only for validation of the measure, are 
confused behavior and staring, absence of friendly behavior, and hostile behavior.   
Acceptance and Action Questionnaire II (AAQII) (Bond et al., 2011).  The 
AAQII is a 7-item instrument used to measure the construct of acceptance.  More 
specifically, it is a measure of experiential avoidance and psychological inflexibility.  
Each item is rated on a 7-point Likert scale ranging from 1 (never true) to 7 (always 
true).  Total cores on the AAQII range from 7 to 49.  Higher scores indicate greater 
psychological inflexibility (Bond et al., 2011).  There is no established cutoff for the 
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AAQII; however, scores above a range of 24 to 28 are associated with higher levels of 
psychological distress.  Lower scores indicate greater psychological flexibility, or greater 
levels of acceptance (Bond et al., 2011).  Psychometric analysis of this measure indicates 
satisfactory reliability and validity.  The mean alpha coefficient was 0.84, and the 3- and 
12-month test-retest reliability was .81 and .79, respectively.  These results show that the 
AAQII appears to measure the same concept as the AAQ, but with better psychometric 
consistency (Bond et al., 2011).  In addition to its sound reliability, validation studies 
indicate that the AAQII demonstrated good construct validity (Bond et al., 2011).  For 
example, higher levels of psychological inflexibility, as measured by the AAQII are 
concurrently associated with greater depressive symptoms (r = .71 with the BDI-II), 
anxiety-related symptoms (r = .61 with the BAI), and overall psychological distress (r = 
.30 with the General Health Questionnaire).   
Procedure 
Selected organizations were contacted via Email, providing them with a 
recruitment message to post through listservs and website postings.  The 
introductory/organizational recruitment Email explained the purpose of the study and 
offered subjects access to the results of the study upon completion.  They were provided 
with a participant recruitment posting to utilize at their discretion.  This same participant 
recruitment message was also posted and advertised on social media networks, such as 
NF groups on Facebook.  Participants were also recruited via snowball sampling, 
Facebook pages and other general social media networks, and by word of mouth. 
The study was available only to those with access to the Internet.  Each 
participant was provided with a document of study summary, including the study’s 
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purpose and procedures.  Participation in this project was voluntary for all subjects, and 
they retained the right not to participate or to withdraw at any time without explanation or 
penalty.  All participants remained completely anonymous.  No names were collected.  
Only demographic information was gathered from participants.  A separate, optional 
sweepstakes incentive (two $50 gift cards) was offered to all respondents willing to 
provide contact information, but there was no link between participant identities and their 
responses.   
Upon agreeing to participate in the study, respondents completed an eligibility 
screening questionnaire (Appendix A).  If they did not meet inclusion criteria, they were 
thanked for their time and redirected from the survey link.  If deemed to meet eligibility 
criteria, participants completed a brief demographic questionnaire (Appendix B) that 
supplied descriptive data, including age, age at NF1 diagnosis, gender, and ethnicity.  
They were then provided access to the four measures (the ICD, Ablon scale, PSQ, and 
AAQII) via Survey Monkey, a widely accepted website used to collect survey data.  
Anticipated duration of participation in the study was approximately 45 minutes.  After 
participants completed the measures, data was confidentially stored and uploaded into 
SPSS 24.0 for statistical analysis, where it was encrypted and stored on a password-
protected computer.   
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Chapter 5: Results 
 
To examine the first hypothesis, a multiple regression was conducted to 
investigate whether the frequency of cognitive distortions and level of perceived 
stigmatization predict the level of acceptance.  A multiple regression was also conducted 
to investigate the second hypothesis that the frequency of cognitive distortions and rating 
of disease visibility would predict the level of perceived stigmatization.  A simple 
regression was conducted to determine if the age at NF1 diagnosis predicted level of 
acceptance (H3).  
Statistical Analyses 
 
 The variables were analyzed using SPSS 24.0.  A G*Power analysis was 
conducted to determine the necessary sample size for the present study.  In this analysis, 
the effect size was set to medium, the significance level was set at 0.05, and the power 
level was set at 0.80, according to conventional standards (Cohen, 1988, 1992).  This 
analysis determined that a minimum of 67 participants was needed to perform the 
multiple regression analyses.  Allowing for attrition/incomplete protocols, especially 
given potential cognitive limitations of this population, the maximum number of 
participants was set at 200. 
Demographic Analysis 
 
 The sample consisted of 48 participants: 37 females and 11 males.  Initially, 202 
participants began the study; however, there was a high attrition rate during completion 
of the survey.  The participant age range was 19 to 64, with a mean age of 41.  
Participants identified as 89.6% White, 6.3% Asian, 2.1% mixed race, and 2.1% ethnicity 
unspecified.  Of the participants who completed the study, 10% endorsed a diagnosis of 
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ADHD, 42% endorsed a diagnosis of depression, 40% endorsed a diagnosis of anxiety, 
and 23% endorsed a diagnosis of a learning disability.   
To examine whether the frequency of cognitive distortions and level of perceived 
stigmatization predicted the level of acceptance among adults diagnosed with NF1, a 
multiple linear regression was conducted using frequency of cognitive distortions (as 
measured by the ICD) and level of perceived stigmatization (as measured by the PSQ) as 
the predictor variables and level of acceptance (as measured by the AAQII) as the 
criterion variable.   
Tests of assumptions of a multiple linear regression were met.  According to Field 
(2009), the Durbin-Watson statistic tests for “serial correlations between errors in 
regression models” (p.  874) and can vary between 0 and 4.  The Durbin-Watson statistic 
in this multiple regression was 2.38, indicating that the residuals are uncorrelated.  
Collinearity diagnostics revealed that for each of the predictor variables, there was no 
evidence of significant multicollinearity.  In this analysis, tolerance statistics had a value 
of .87 suggesting that multicollinearity was not a concern.  Tolerance statistics should not 
be below 0.1 and even values below .2 can be a concern (Field, 2009).  The variance 
inflation factor value was found to be 1.15 for both variables, indicating no concern.  A 
plot of standardized residuals against standardized predicted values revealed that 
assumptions of linearity and homoscedasticity were met.  A histogram and normal 
probability plot of residuals were examined and revealed that the assumption of normality 
was also met.  The normal probability plot examining observed cumulative percentages 
to expected cumulative percentages also supported the assumption of normality; the 
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probability-probability (P-P) scatter plot showed some mild deviation around the line, but 
was generally consistent with what would be expected in terms of normality. 
The overall regression analysis, as shown in Table 1, revealed a significant 
regression, F(2, 47) = 53.304, p = .001, indicating that the combination of these 
predictors made a significant contribution to the prediction of acceptance.  The results of 
the multiple linear regression analysis, as shown in Table 2, revealed a multiple 
correlation of R = .839, with a coefficient of determination of .703 (R2 = .703), indicating 
that approximately 70% of the variance observed can be attributed to the combination of 
frequency of cognitive distortions and perceived stigmatization.  The adjusted coefficient 
of determination (R2adj = .690) suggests that there would be some shrinkage from sample 
to general population.  An examination of each of the predictor variables, as shown in 
Table 3, revealed that only one of the predictors, frequency of cognitive distortions, made 
a significant contribution to the level of acceptance.   
Table 1 
Overall Regression Analysis With Predictor Variables (Cognitive Distortions and 
Perceived Stigmatization) to the Dependent Variable (Acceptance)  
 
Model SS df MS F p 
1 Regression 3398.82 2 1699.41 53.30* .000b 
   Residual 1434.66 45    31.88   
   Total 4833.48 47    
 
a = Criterion variable: level of acceptance 
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Table 2 
Model 1 Summary of the Predictor Variables (Cognitive Distortions and Perceived 
Stigmatization) to the Dependent Variable (Acceptance) 
 
Model R R2 R2Adj SEE R2 
Change 
F 
Change 
df1 df2 Sig.  F 
Change 
Durbin-
Watson 
1 .884a* .70 .690 5.65 .70 53.30 2 45 .001 2.38 
 
 
Table 3 
Coefficients of Predictor Variables (Cognitive Distortions and Perceived Stigmatization) 
to the Dependent Variable (Acceptance) 
 
 Unstandardized 
Coefficients 
 Standardized 
Coefficients 
  Collinearity 
Statistics 
 
Model B SE ß t p Tolerance VIF 
1 (Constant) -14.55 4.48  -3.25 .002   
Inventory of 
cognitive 
distortions  
     .16   .02 .76  8.73  .000* .87 1.15 
Stigma   3.78 1.90 .17  1.99 .053 .87 1.15 
 
 
 To examine whether the frequency of cognitive distortions and rating of disease 
visibility predicted the level of perceived stigmatization, a multiple linear regression 
analysis was conducted, using frequency of cognitive distortions (as measured by the 
ICD) and rating of disease visibility (as measured by the Ablon Scale) as predictor 
variables and the level of perceived stigmatization (as measured by the PSQ) as the 
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criterion variable.  The tests of assumptions of the analysis were met with the Durbin-
Watson (2.03) and tolerance statistics (.95) and variable inflation factors (1.05).  These 
values suggest no significant multicollinearity.  A plot of standardized residuals against 
standardized predicted values revealed that assumptions of linearity and homoscedasticity 
were met.  A histogram and normal probability plot of residuals were examined and 
revealed that the assumption of normality was also met.  The normal probability plot 
examining observed cumulative percentages to expected cumulative percentages also 
supported the assumption of normality; the probability-probability (P-P) scatter plot 
showed some mild deviation around the line, but was generally consistent with what 
would be expected in terms of normality. 
 The overall regression analysis, as shown in Table 4, revealed a significant 
regression, F(2, 47)) = 8.024, p = .001, indicating that the combination of these 
predictors, frequency of cognitive distortions and rating of disease visibility, made a 
significant contribution to the predication of perceived stigmatization.  The results of the 
multiple linear regression analysis, as shown in Table 5, revealed a multiple correlation 
of R = .513, with a coefficient of determination of .263 (R2 = .263), indicating that 
approximately 26% of the variance observed can be attributed to this combination of 
cognitive distortions and rating of disease visibility.  The adjusted coefficient of 
determination (R2Adj = .230), suggests that there would be some shrinkage from sample 
to population if the population had been evaluated.  An examination of frequency of 
cognitive distortions and rating of disease visibility individually, as shown in Table 6, 
revealed that both make a significant contribution to the level of stigmatization.   
 
COGNITIVE DISTORTIONS AND NF1   63 
Table 4 
Overall Regression Analysis With Predictor Variables (Cognitive Distortions, and 
Disease Visibility) to the Dependent Variable (Perceived Stigmatization)  
 
Model SS df MS F p 
1 Regression   2.67 2 1.34 8.02* .001b 
   Residual   7.49 45  .17   
   Total 10.16 47    
 
a = Criterion variable: perceived stigmatization. 
 
Table 5 
Model 1 Summary of the Predictor Variables (Cognitive Distortions, and Disease 
Visibility) to the Dependent Variable (Perceived Stigmatization) 
 
Model R R2 R2Adj SEE R2 
Change 
F 
Change 
df1 df2 Sig.  F 
Change 
Durbin-
Watson 
1 .51a* .26 .23 .41 .26 8.02 2 45 .001 2.03 
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Table 6 
Coefficients of Predictor Variables (Cognitive Distortions, and Disease Visibility) to the 
Dependent Variable (Perceived Stigmatization) 
 
 Unstandardized 
Coefficients 
 Standardized 
Coefficients 
  Collinearity 
Statistics 
 
Model B SE ß t p Tolerance VIF 
1 (Constant) 1.24 .27  4.61 .000   
Inventory of 
cognitive 
distortions  
  .00 .00 .28 2.15 .037*    .95 1.05 
Visibility   .25   .09 .37 2.84 .007* .95 1.05 
 
 
 To examine whether the age at diagnosis of NF1 was a significant predictor of 
level of acceptance, a simple linear regression was conducted using the age at diagnosis 
as a predictor variable and the level of acceptance (as measured by the AAQII) as the 
criterion variable.  Assumptions of a simple regression were met.  A plot of standardized 
residuals against standardized predicted values revealed that assumptions of linearity and 
homoscedasticity were met.  A histogram and normal probability plot of residuals were 
examined and revealed that the assumption of normality was also met.  The normal 
probability plot examining observed cumulative percentages to expected cumulative 
percentages also supported the assumption of normality; the probability-probability (P-P) 
scatter plot showed some mild deviation around the line, but was generally consistent 
with what would be expected in terms of normality.   
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 Results indicated that there was no significant relationship between age at 
diagnosis and level of acceptance (r = .020, p = .894).  Correlations and coefficients are 
presented in Table 7 and Table 8, respectively.   
Table 7 
Model 1 Summary of Predictor Variables (Age at Diagnosis) to the Dependent Variables 
(Level of Acceptance AAQ) 
 
Model r R2 R2Adj SEE 
1 .02a .00 -.021 10.25 
 
a = Predictors: (constant): At what age were you diagnosed with NF1 
 
Table 8 
Coefficients of Predictor Variables (Age at Diagnosis) to the Dependent Variables (Level 
of Acceptance AAQ) 
 Unstandardized 
Coefficients 
 Standardized 
Coefficients 
  
Model B SE ß t p 
(Constant) 24.61 2.18  11.31 .00 
At what age were 
you diagnosed 
with NF1  
-.02 .12 -.02 -.13 .89 
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Chapter 6: Discussion 
 This study examined the relationship between cognitive distortions, perceived 
stigmatization, and acceptance among adults with NF1, a disorder that is characterized by 
a number of signs and symptoms, some of which are highly visible and disfiguring.  
Although NF1 has gained a great deal of attention and research in the medical field, this 
study aimed to provide information from a psychological and cognitive perspective.  
There is currently little research exploring the underlying cognitive and psychological 
mechanisms associated with NF1.  Previous research demonstrated the role of cognitive 
distortions among a variety of psychiatric concerns, including both clinical syndromes 
and personality disorders (e.g., Rosenfield, 2004), many of which are comorbid with 
NF1.  However, to date, there has been no research exploring the role of cognitive 
distortions among the NF1 population and how these cognitions impact different 
perceptions and reactions.  Furthermore, because NF1 has signs that are often visible in 
impersonal interactions, those with the disorder may be subject to stigmatizing behavior 
by others, which can foster emotional distress.  The construct of acceptance, or the ability 
to engage in psychological flexibility, may have considerable relevance in the NF1 
population as an adaptive means of coping with physical disfigurements and the reactions 
of others.  A literature review revealed scant research exploring acceptance in the NF1 
population.  The goal of this study was therefore to begin to address these gaps in the 
literature.   
Findings and Clinical Implications 
 Cognitive distortions, stigmatization, and acceptance.  The current study 
initially found that together, cognitive distortions and perceived stigmatization 
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significantly predicted level of acceptance; however, when examined independently, it 
was determined that only cognitive distortions were significantly associated with level of 
acceptance.  Nonetheless, the fact that perceived stigmatization was not found to be a 
significant predictor in this study seems to demonstrate the central role cognitive 
distortions in acceptance for this population.  These findings have substantial 
implications for treatment planning and interventions.   
 As research has shown, higher levels of acceptance, or psychological flexibility, 
are associated with lower levels of depression and anxiety (Hacker et al., 2016), both of 
which are common among those with NF1.  Among individuals with chronic pain, 
research has shown that higher levels of acceptance result in a greater quality of life 
(Dahl, 2009).  Individuals with NF1 often report chronic painful physical symptoms.  
Extrapolating from these findings to the NF1 population, increased level of acceptance 
would benefit this population.   
There are different approaches clinicians can take to address level of acceptance.  
The most common treatment modality is acceptance and commitment therapy and 
acceptance has been addressed implicitly and explicitly in cognitive therapy nearly from 
its inception (Beck, 1976, 1979).  However, ACT elevates acceptance to primary 
importance and the focus of treatment, in contrast to standard CBT, in which acceptance 
has always been an integral element (e.g., Beck, 1979).  There are various processes 
within the ACT model in order to establish psychological flexibility: experiential 
acceptance, cognitive diffusion, contact with the now, self-as-context, values, and 
committed action (Hayes et al., 2013).  Many have posited that ACT has utility in the 
context of long-term conditions (Angiola & Bowen, 2013; Graham, Simmons, Stuart, & 
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Rose, 2015; Hadlandsmyth, White, Nesin, & Greco, 2013; Whittingham, 2014).  For 
example, negative illness-related beliefs and distress may be realistic in certain conditions 
at certain times.  Therefore, ACTs focus on investigating valued behaviors while 
accepting such thoughts and feelings may be more effective than attempts to alter these 
distressing but accurate cognitions (Graham et al., 2015; Low et al., 2012).   
Some researchers have suggested that nonadherence to HIV medication or poor 
diabetes self-management is related to avoidance of disease-related thoughts and feelings, 
such as fear or shame (Hadlandsmyth et al., 2013; Moitra, Herbert, & Forman, 2011).  
ACTs focus on encouraging acceptance in the service of meaningful and, in this case, 
salubrious behavior may be particularly useful for disease self-management or adherence 
to medical recommendations (Graham et al., 2016).  There is increasing evidence that 
ACT techniques are widely implemented by health professionals treating long-term 
conditions (Thewes et al., 2014).  Some of these conditions include cancer, epilepsy, 
pediatric illness, cardiac disease, multiple sclerosis, and diabetes, and the range of 
conditions and applications demonstrates the flexibility of the ACT model (Graham et al., 
2016). 
Mindfulness-based stress reduction (MBSR) is another treatment for 
psychological distress, depressive symptoms, and anxiety for people with chronic disease 
that is rapidly growing in popularity in the United States.  MBSR was developed by 
Kabat-Zinn in 1979 and was traditionally used for chronic pain (Kabat-Zinn, 1990).  It is 
considered an ACT intervention that involves mindfulness meditation.  Mindfulness is 
most typically defined as “paying attention in a particular way: on purpose, in the present 
moment, and non-judgmentally” (Kabat-Zinn, 1994, p.4).  Mindfulness includes at least 
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three components: attentional control, the intention of attentional control (e.g., to 
decenter from negative thinking), and attitudes that are being trained (e.g., approach 
orientation and nonjudgment); (Alsubaie et al., 2017).  MBSR has now been applied in 
people with chronic diseases such as cancer, fibromyalgia, and heart failure; it has 
positive effects on pain, anxiety and stress in people with chronic disorders such 
as fibromyalgia, coronary artery disease, back pain, and arthritis (Bohlmeijer, Prenger, 
Taal, & Cuijpers, 2010; Grossman, Niemann, Schmidt, & Walach, 2004; Rosenzweig et 
al., 2010).  In recent systematic reviews examining MBSR interventions among people 
with physical and/or psychological conditions, researchers reported MBSR as a 
promising approach to cope with symptoms related to chronic illness; however, future 
research is warranted (Ahola Kohut, Stinson, Davies-Chalmers, Ruskin, & van Wyk, 
2017; Alsubaie et al., 2017).  To date, there are no studies examining MBSR with the NF 
population.  However, the literature suggests that the intervention may play a role in 
reducing physical pain and comorbid anxiety related to the disorder.   
Results of this study demonstrated an association between frequency of cognitive 
distortions and acceptance, supporting the notion that targeting cognitive distortions 
within the NF1 population may increase level of acceptance.  Cognitive therapy is an 
effective treatment in modifying maladaptive beliefs and ameliorating cognitive 
distortions.  If the frequency of cognitive distortions predicts level of acceptance, 
clinicians can aim to reduce distortions and ultimately improve their level of acceptance.  
Characteristics of CBT suit this population, as it is a short-term treatment that has 
demonstrated efficacy for a wide range of psychiatric and medical problems and health-
related behaviors (Beck, 1995; Marcinko, 2003; Senecal, Nouwen, & White, 2000).  CBT 
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aims to identify, evaluate, and respond to dysfunctional thoughts and beliefs (i.e.  
cognitive distortions) and modify maladaptive behavior and emotion (Beck, 1995).   
 CBT can address the underlying cognitive distortions in NF1 patients and has 
been adapted specifically for individuals with ADHD.  Approximately 10% of study 
participants had a diagnosis of ADHD, and previous research shows that up to 60% of 
NF1 patients report a diagnosis of Learning Disability (LD) or ADHD (Tonsgard, 2006).  
Adults with ADHD may have greater difficulty using cognitive modification strategies 
and are likely to have had numerous disappointments in their life, contributing to their 
maladaptive belief systems (Ramsay, 2017).   
 Based on an understanding that adults with ADHD struggle with performance of 
desired actions (and not with a lack of knowledge), current manualized treatments of 
CBT for ADHD emphasize the consistent implementation of the coping strategies 
necessary to manage the effects of ADHD (Ramsay, 2017).  Cognitive interventions help 
target the escape-avoidance coping style seen in ADHD and help promote engagement in 
tasks and follow-through on therapeutic coping strategies that would be helpful for the 
NF1 population (Ramsay, 2017).  Because CBT has been and can be adapted for 
individuals with various cognitive limitations and directly targets cognitive distortions, 
CBT is a prime candidate for successful treatment of the NF1 population.   
 It is hoped that if clinicians can successfully target cognitive distortions, there will 
be an increase in acceptance among the NF1 population.  Additionally, clinicians can use 
ACT interventions such as mindfulness to increase psychological flexibility, or 
acceptance.  In turn, individuals with NF1 would experience fewer symptoms of pain, 
depression, and anxiety and would report a better quality of life.   
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Cognitive distortions, disease visibility, and perceived stigmatization.  The 
current study found that together, cognitive distortions and self-rating of disease visibility 
were associated with perceived stigmatization.  When examined independently, both the 
frequency of cognitive distortions and rating of disease visibility were associated with or 
predicted perceived stigmatization.  This means that those who viewed their NF1 as more 
visible perceived more social stigmatization and engaged in more cognitive distortions.  
Consequently, if it is hoped that if the frequency of cognitive distortions predicts 
perceived stigmatization, clinicians directly treat cognitive distortions with CBT and 
thereby reduce perception of stigmatization and the attendant dysphoria.  Although 
results found that perceived stigmatization did not significantly predict acceptance, 
cognitive distortions were associated with both acceptance and perceived stigmatization, 
making the cognitive distortions a prime target to increase acceptance and perceived 
stigmatization. 
Although addressing cognitive distortions will help to reduce levels of perceived 
stigmatization among those with NF1, it is also important to consider interventions to 
help patients with NF1 cope with stigmatizing behaviors.  A meta-analysis of stigma 
studies conducted in 2009 reported that active and problem-focused coping approaches 
may be more effective than passive or emotion-focused coping approaches addressing 
perceived health stigmatization (Pascoe & Richman, 2009).  This review also reported 
that social support, engagement with an identity group (in this case, peers with NF1), and 
development of an active coping style can reduce the impact of stigma on stress, which 
ultimately reduces negative mental and physical well-being.  Various studies have been 
conducted to determine if interventions reduce self-stigma.  These studies have found that 
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psychosocial education (to replace stigmatized views about mental illness and recovery) 
in combination with CBT (teaching skills to challenge negative beliefs about the self) are 
effective in reducing self-stigmatization by persons with mental illnesses, HIV, and 
internalized weight stigma (Heijnders & Van der Meij, 2006; Mittal, Sullivan, Chekuri, 
Allee, & Corrigan, 2012; Pearl et al., 2016).  It is hoped that NF1 patients can reduce 
negative social interactions and increase positive interactions through social skills 
training, cognitive and behavior therapies, support groups, and improving relationships 
with family, friends, and providers (Mouradian, 2001).  Rumsey and Harcourt (2007) 
recommended that physicians use screening tools to routinely assess whether patients 
have experienced discrimination in order to make necessary therapeutic referrals. 
Results of the present study showed that the majority of participants, 52%, rated 
their disease visibility as moderate (some tumors on neck, face hands; mild scoliosis or 
other skeletal features without noticeable limp).  The remaining participants rated their 
disease visibility as mild (31%; no visible tumors with normal gait and posture) or severe 
(16%; numerous tumors on the face, optic glioma that has affected sight and eye socket, 
and severe skeletal features with noticeable limp).  Research shows that patients with 
greater concern about the visibility of their disease are at higher risk of developing low 
self-esteem, self-rejecting cognitions, problems in interpersonal relationships, and 
negative body image (Rumsey & Harcourt, 2004).  Considering the proportion of 
participants that rated their visibility as moderate, we can infer the presence of 
subsequent concerns such as low self-esteem and negative body image.  Clinicians can 
utilize ACT to increase acceptance of body image, which focuses on body image 
flexibility.  Body image flexibility is the ability to openly experience body image 
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dissatisfaction and related experiences in a way that promotes adaptive life functioning 
and values-consistent behavior (Sandoz et al., 2013).  Specifically, body image flexibility 
involves openly engaging painful or unwanted thoughts and emotions regarding one’s 
body size, shape, or weight with mindful acceptance (Sandoz et al., 2013).  The treatment 
goal is to focus on the relationship with the body image-related cognitions and emotions 
rather than change them, thereby reducing the emotional toll (Lee et al., 2017).   
Age at diagnosis and acceptance.  Results of this study indicated that there is no 
significant relationship between the age at first NF1 diagnosis and level of acceptance.  
This implies that living with the condition for a longer period, alone, does not inherently 
foster increased acceptance.  With this in mind, clinicians can likely implement the 
aforementioned interventions with NF1 patients regardless of either their age at onset or 
current age.  Emerging research on ACT in the treatment of children is encouraging for 
the utility of this therapeutic approach (Swain, Hancock, Dixon, & Bowman, 2015).  A 
pilot study examining the use of ACT with youth with NF1 and chronic pain 
demonstrated that small group ACT workshops seem to be a feasible and effective 
intervention (Martin et al., 2016).  In regards to CBT, results from a meta-analysis 
suggest that CBT is an efficacious treatment for anxiety and depression among children 
(Crowe & McKay, 2017), although a literature review revealed no such studies specific 
to NF1.   
 Taken together, findings from this study highlight the relationship between 
cognitive distortions and acceptance among this population, with approximately 70 
percent of the variance in acceptance attributable to cognitive distortions.  This is 
evidence for the overlap in treatment models, or more accurately, a false dichotomy 
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between ACT and Beckian CBT.  These findings support the importance of being able to 
utilize a variety of interventions to best suit individual patients.  Both ACT and so-called 
second wave CBT stress the importance of cognitions in the role of psychopathology, 
although they differ in the degree of emphasis on, and their approach to cognitions 
(Herbert & Forman, 2013).  Not only can clinicians choose interventions that specifically 
target cognitive distortions, but they can choose brief cognitive interventions that suit the 
cognitive limitations of this population.  Results also stress the importance of acceptance 
among individuals with NF1 and how to best implement interventions to serve this 
population.   
 It is also important to recognize how patients perceive their own physical 
symptoms and how this can result in the perception of stigmatization.  Screening and 
assessing perceived stigmatization can help clinicians tailor therapeutic treatment to help 
patients cope with those perceptions and the painful emotional sequelae.  It is hoped that 
findings from this study provide context and direction for how clinicians may 
conceptualize and work with individuals with NF1 and other related medical disorders.  
More specifically, it is hoped that this study provides guidance in working with disorders 
with visible signs that result in stigmatization and subsequent psychological impacts.   
Limitations 
 As with any research, this study has limitations.  As research has shown, those 
with NF1 are at increased risk of depression and anxiety.  The current study did not 
control for the confounding variables of comorbid psychiatric concerns, which could 
explain the presence of cognitive distortions.  Individuals with diagnosed (and 
undiagnosed) anxiety, depression, ADHD, LD, etc.  were able to participate in this study.  
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Of the 48 participants, 10% reported being previously diagnosed with ADHD, 42% had 
been diagnosed with depression, 40% had been diagnosed with anxiety, and 23% had 
been diagnosed with a learning disability.   Previous researchers found that up to 55% of 
NF1 patients scored above a 16 on the CESD scale, indicating a high likelihood of 
clinical depression (Cohen, 2015).  Although research shows that there is no relationship 
between ADHD and cognitive distortions, both anxiety and depression have been 
previously correlated with cognitive distortions (Rosenfield, 2004; Serine, 2016). 
 The sample size of the current study is a major limitation and negatively impacts 
the external validity of the results.  Although the study had over 200 participants who 
started the survey (n = 202), there was a high dropout rate during the self-reports, 
resulting in a smaller sample (n = 48).  It can be hypothesized that this high rate of 
attrition was due to the cognitive limitations of this population.  Furthermore, there was 
feedback from participants that questions in the survey were very personal in nature, 
perhaps too personal to pursue, leading to avoidance and premature termination.   
 Demographically, there was an unequal number of male (11) and female (37) 
participants in the study.  Research has shown that females with NF1 report major 
concern with the visibility of clinical manifestations, whereas males report less concern 
(Hummelvoll & Antonsen, 2013).  This could greatly impact levels of perceived stigma 
or rating of disease visibility.   
 The self-report nature of the measures is also a potential limitation.  Self-report in 
psychological research is a popular method for collecting data.  Advantages of self-report 
include easy interpretability, richness of information, motivation to report, causal force, 
and sheer practicality (Lucas & Baird, 2006).  Self-reports are often communicated in a 
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language common to the investigator and the respondent (Paulhus & Vazire, 2007).  A 
wealth of information can be gained via self-report, including feelings and thoughts, and 
there is a quantity and breadth of information that can be reported (Paulhus & Vazire, 
2007).  Causal force refers to the idea that self-report engages a respondent’s identity 
(Hogan & Smither, 2001) and that self-perceptions have a strong influence on how 
people interact with their environment and others (Paulhus & Vazire, 2007).  Lastly, self-
reports are extremely practical in that they are inexpensive and efficient.  They can be 
administered to a large group of people, and multiple variables can be assessed in one 
session (Paulhus & Vazire, 2007).  Despite these advantages, there are clear limitations to 
using the self-report method to collect data.  The most salient concern is the reactive 
nature of the method and questions about subsequent validity.  There are response sets 
and styles that may interfere with the validity of self-reported data.  Some common 
examples are socially desirable responding, acquiescent responding, and extreme 
responding (Paulhus & Vazire, 2007).  Socially desirable responding may involve 
impression management (exaggeration, faking, lying) or self-deception (self-favoring 
bias, self-enhancement, defensiveness, and denial) (Paulhus & Vazire, 2007).  
Acquiescent responding refers to agreeing with statements without regard to their 
content, and some researchers believe that acquiescent responding may be related to a 
personality trait linked to conformity and impulsiveness (Couch & Kenniston, 1960).  
Lastly, extreme responding (ER) refers to the tendency to use the extreme choices on a 
rating scale, for example, rating all 1s or 7s on a Likert scale); (Paulhus & Vazire, 2007).   
A major concern with ER bias is that it may induce false correlations among variables.  
Specific to this study, ER bias may indicate a relationship between cognitive distortions, 
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stigmatization, and acceptance that is not necessarily significant.  This would undermine 
the results and implications for treatment.   
 In addition to the aforementioned concerns regarding self-reports, participants in 
this study were required to provide accurate and, presumably, honest reports regarding 
their NF diagnosis along with all of the other data.  Individuals may also misreport 
information, which could have an impact on results and findings. 
Future Directions 
 Although it is useful to have information and knowledge that will help in guiding 
psychological care, this information will be useless if NF patients do not seek treatment.  
Researchers may want to conduct exploratory studies examining the likelihood of seeking 
psychological treatment in this population.  It would be beneficial to determine whether 
psychological treatment is being utilized among this population and if these patients are 
open to seeking psychological treatment.    
 Based on the findings of this study, researchers may want to explore other 
treatments and interventions regarding body image and visibility of NF1.  Future studies 
investigating specific therapeutic techniques aimed at reducing negative body image and 
potentially related emotional distress could be beneficial.  Furthermore, the current study 
examined visibility as rated by the NF1 patients.  Because findings show that cognitive 
distortions play a large role among perceptions of stigmatization in this group, it is likely 
that cognitive distortions play a role in their perception of visible symptoms.  Future 
studies can compare self and other visibility ratings to determine accuracy.   
 In future research, because depression is previously associated with cognitive 
distortions, depression should be screened and statistically accounted for in order to 
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measure cognitive distortions specific to NF1, regardless of level of depression.  
Similarly, anxiety, ADHD, and LD should also be screened and statistically accounted 
for when conducting analyses. 
Because CBT has been and can be adapted for individuals with various cognitive 
limitations and directly targets cognitive distortions, CBT is a prime candidate for 
successful treatment within the NF1 population.  To date, there are no studies that have 
specifically examined CBT as an intervention with his population.  It is hoped that the 
results of this study spark interest for CBT interventions to address cognitive distortions.   
In regards to stigmatization, results of this study showed that perceived 
stigmatization is associated with levels of acceptance.  This population does experience 
negative social interactions due to the physical manifestations of this disorder.  It is 
hoped that NF1 patients can increase positive interactions through social skills training, 
cognitive and behavior therapies, support groups, and improving relationships with 
family, friends, and providers (Mouradian, 2001).  By improving social relationships and 
social interactions, patients with NF1 may experience higher levels of acceptance.   
Future researchers may wish to investigate acceptance and commitment and 
mindfulness-based interventions with this population, as the literature suggests that these 
interventions may play a role in reducing physical pain and comorbid anxiety related to 
the disorder.  Although there have been pilot studies examining the effectiveness of ACT 
among youth with NF1, a gap in the research remains.    
Because NF1 is typically diagnosed during childhood, it would be interesting to 
consider how the disorder manifests in regards to various attachment styles and 
development.  This can be studied with cross-sectional and longitudinal designs.  
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Attachment theory was developed by psychiatrist John Bowlby to explain the tendency of 
humans to form close affectionate bonds (Bowlby, 1969).  Bowlby hypothesized that 
security of attachment derives from caregivers’ reliable and sensitive provision of love 
and comfort, as well as food and warmth (Levy, Johnson, Clouthier, Scala, & Temes, 
2015).  Infants with caregivers who meet their biological and psychological needs turn to 
their caregivers when experiencing distress or fear (Bowlby, 1969).  Ainsworth, Blehar, 
Waters, and Wall (1978) adapted Bowlby’s conceptualization of attachment differences 
in a seminal study.  This study identified three major attachment styles: secure, anxious-
ambivalent, and avoidant.  Securely attached children seek closeness to their caregiver, 
indicate distress at separation, and demonstrate moderate interest in a stranger.  Anxious-
ambivalent children exhibit heightened distress at separation, are difficult to comfort 
when their caregiver returns, and require constant attention from their caregiver.  
Avoidant children do not appear distressed by separation from caregiver, may ignore the 
caregiver upon return, and treat a stranger and caregiver similarly.  A fourth style, 
disorganization, was later added by Main and Solomon (1986).  This style is 
characterized by confused and disoriented behaviors.  Attachment theory has led to 
extensive research in developmental, personality, and clinical psychology; however, it is 
rarely explored within the medical field (Schmidt, Nachtigall, Wuethrich-Martone, & 
Strauss, 2002).  There are two reasons why attachment theory would be suitable to apply 
as a theory of coping within a medical context.  First, attachment theory is able to predict 
the vulnerability or resilience to stressful life events (Bowlby, 1988).  More specifically, 
attachment theory may predict why some individuals can shift from one strategy to 
another, whereas others hold on to rigid methods of coping (Grossmann et al., 1989).  
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Secondly, Bowlby believed that the attachment behavioral system is activated in times of 
stress and disease (Bowlby, 1988).  Despite these points, the relationship among 
attachment, affect regulation, and coping has rarely been investigated within the context 
of coping with chronic disease.  In a study of individuals with breast cancer, chronic leg 
ulcers, and diffuse and androgenetic alopecia, researchers found a significant relationship 
between attachment styles and coping strategies.  Specifically, ambivalently attached 
individuals showed high elevations on all of the three coping dimensions of diverting, 
negative emotional, and seeking attention and care, whereas avoidant attached individuals 
showed low scores on all coping dimensions (Schmidt et al., 2002).    
Consequently, it may be warranted to explore attachment theory in NF1.  
Researchers may also wish to examine attachment styles longitudinally, comparing 
young children with NF1 to subsequent adult attachment style as they enter romantic and 
committed relationships, e.g., attachment style as it relates to physical symptoms and 
intimacy.   
Lastly, as this study had an unequal number of male and female participants, 
future researchers may wish to consider gender differences in cognitive distortions, 
perceived stigmatization, and acceptance in this population.   
Summary and Conclusions 
This study examined the relationship between cognitive distortions, perceived 
stigmatization, and acceptance in NF1.  Results demonstrated that together, the frequency 
of cognitive distortions and level of perceived stigmatization are predictive of acceptance.  
Additionally, the frequency of cognitive distortions and rating of disease visibility was 
predictive of perceived stigmatization.  These findings suggest that cognitive distortions 
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play a significant role in this population regarding their perceptions and internal 
experiences of the disorder.  It is hoped that if clinicians successfully target cognitive 
distortions, there will be an increase in acceptance among the NF1 population.  
Additionally, clinicians can use ACT interventions such as mindfulness to increase 
psychological flexibility or acceptance.  Individuals with NF1 will then experience fewer 
symptoms of pain, depression, and anxiety and report a higher quality of life.   
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Appendix A 
Screening Questionnaire 
Please respond Yes or No to the following questions: 
1. Are you between the ages of 18-65? 
2. Do you have an 8th grade education or higher? 
3. Have you ever been diagnosed with an intellectual disability? 
4. Have you ever been diagnosed with NF1?  
5. Are you currently experiencing 2 or more of the following symptoms: 
a. Dark flat spots on your skin that doctors call café au lait spots. 
b. Nerve tumors that appear as purplish depressions in the skin or sores that 
stick out from the skin that doctors call neurofibromas, or any type of 
plexiform neurofibroma. 
c. Bone abnormalities that could include absence of bone around the eye, 
bone development that is not normal, bone tumors that are not cancer, or 
scoliosis.   
d. Someone else in your family was diagnosed with NF1, such as parent, 
grandparents, brother, sisters, etc. 
e. Reddish brown spots in the colored part of your eye that doctors call Lisch 
Nodules. 
f. Freckling in armpit or groin region. 
g. Tumors on the visual pathway causing thickening of optic nerve that 
doctors call Optic Pathway Glioma.   
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6. In the past month, have you seen or heard things that other people have not seen 
or heard? 
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Appendix B  
Brief Demographic Questionnaire 
Please read and answer the following questions: 
 
1. How old are you? 
 
2. At what age were you diagnosed with NF1? 
 
3. What is your gender? 
a. Male 
b. Female 
c. Other 
 
4. Which of the following best represents your ethnicity? 
a. American Indian or Alaska Native 
b. Asian 
c. Black or African American 
d. Hispanic or Latino 
e. Native Hawaiian or Other Pacific Islander 
f. White 
g. Mixed race 
h. Other 
 
5. What country do you live in? 
 
6. Do you have any of the following: 
a. Psoriasis 
b. Congenital abnormalities 
c. Acne Vulgaris 
d. Skeletal Dysplasia  
e. HIV/AIDS 
f. NF1 
 
7. If you have any of these physical conditions, above which do you find to be the most 
distressing? 
a. Psoriasis 
b. Congenital abnormalities 
c. Acne Vulgaris 
d. Skeletal Dysplasia  
e. HIV/AIDS 
f. NF1 
 
8. Please check conditions for which you have ever been diagnosed 
a. ADHD 
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b. Depression 
c. Anxiety 
d. Learning Disability 
e. None of the Above 
 
9. Please check problems which you are currently getting mental health treatment for 
a. ADHD 
b. Depression 
c. Anxiety 
d. Learning Disability 
e. None of the Above 
 
 
